name,category,terms2'-5'-oligoadenylate synthetase 2, 69/71kDa,INTERPRO[450002588$IPR002934:Nucleotidyltransferase, 450005548$IPR006116:2-5-oligoadenylate synthetase, ubiquitin-like region, 450005549$IPR006117:2-5-oligoadenylate synthetase, conserved site, 450017222$IPR018952:2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal]
2'-5'-oligoadenylate synthetase 2, 69/71kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000881$lipoprotein, 790000959$microsome, 790000969$mitochondrion, 790001004$myristate, 790001063$nucleotide-binding, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001304$repeat, 790001339$rna-binding, 790001547$transferase]
2'-5'-oligoadenylate synthetase 2, 69/71kDa,UP_SEQ_FEATURE[850001029$chain:2'-5'-oligoadenylate synthetase 2, 850102588$compositionally biased region:Pro-rich (linker), 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106259$mutagenesis site, 850113824$region of interest:OAS domain 1, 850113825$region of interest:OAS domain 2, 850117294$sequence conflict, 850118574$splice variant]
A kinase (PRKA) anchor protein 11,INTERPRO[450007659$IPR008382:A-kinase anchor 110 kDa]
A kinase (PRKA) anchor protein 11,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism]
A kinase (PRKA) anchor protein 11,UP_SEQ_FEATURE[850002960$chain:A-kinase anchor protein 11, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850114057$region of interest:PKA-RII subunit binding domain, 850117294$sequence conflict, 850117295$sequence variant]
A kinase (PRKA) anchor protein 3,INTERPRO[450007659$IPR008382:A-kinase anchor 110 kDa, 450016576$IPR018292:A-kinase anchor 110 kDa, C-terminal, 450016733$IPR018459:RII binding domain]
A kinase (PRKA) anchor protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism]
A kinase (PRKA) anchor protein 3,UP_SEQ_FEATURE[850002965$chain:A-kinase anchor protein 3, 850106258$modified residue, 850106259$mutagenesis site, 850114057$region of interest:PKA-RII subunit binding domain, 850117294$sequence conflict, 850117295$sequence variant]
A kinase (PRKA) anchor protein 7,INTERPRO[450017747$IPR019510:Protein kinase A anchor protein, nuclear localisation signal domain, 450017748$IPR019511:Protein kinase A anchor protein, RI-RII subunit-binding domain]
A kinase (PRKA) anchor protein 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001100$palmitate, 790001212$polymorphism]
A kinase (PRKA) anchor protein 7,UP_SEQ_FEATURE[850002970$chain:A-kinase anchor protein 7 isoform gamma, 850002971$chain:A-kinase anchor protein 7 isoforms alpha and beta, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850114237$region of interest:Required for apical membrane localization, 850114425$region of interest:Required for membrane localization, 850114538$region of interest:RII-binding, 850117295$sequence variant, 850118574$splice variant]
ADP-ribosylation factor 1,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets.]
ADP-ribosylation factor 1,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor 1,KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
ADP-ribosylation factor 1,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor 1,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000639$gtp-binding, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
ADP-ribosylation factor 1,UP_SEQ_FEATURE[850004004$chain:ADP-ribosylation factor 1, 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850118575$strand, 850118624$turn]
ADP-ribosylation factor-like 2,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor-like 2,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor-like 2,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor-like 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000639$gtp-binding, 790000811$isopeptide bond, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ADP-ribosylation factor-like 2,UP_SEQ_FEATURE[850000387$binding site:GTP; via amide nitrogen, 850004038$chain:ADP-ribosylation factor-like protein 2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118575$strand]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,INTERPRO[450007946$IPR008689:ATPase, F0 complex, subunit D, mitochondrial]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,PIR_SUPERFAMILY[630005438$PIRSF005514:ATPase_F0_D_mt, 630005439$PIRSF005514:F-type ATP synthase, subunit d, mitochondrial]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000281$cf(0), 790000356$complete proteome, 790000445$direct protein sequencing, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001558$transport]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,UP_SEQ_FEATURE[850006509$chain:ATP synthase subunit d, mitochondrial, 850106258$modified residue, 850118574$splice variant]
B-cell CLL/lymphoma 9,INTERPRO[450014104$IPR015668:B Cell Lymphoma 9]
B-cell CLL/lymphoma 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001642$wnt signaling pathway]
B-cell CLL/lymphoma 9,UP_SEQ_FEATURE[850007049$chain:B-cell CLL/lymphoma 9 protein, 850102565$compositionally biased region:Poly-Ala, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105852$helix, 850106258$modified residue, 850111365$region of interest:CTNNB1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),INTERPRO[450008710$IPR009617:Adipose-regulatory protein, Seipin]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),OMIM_DISEASE[520002905$Lipodystrophy, congenital generalized, type 2, 520003610$Neuropathy, distal hereditary motor, type V, 520004483$Silver spastic paraplegia syndrome, 520004539$Spastic paraplegia 17 (autosomal dominant), 520004540$spastic paraplegia 17 (Silver syndrome), 520004549$Spastic paraplegia with amyotrophy of hands and feet (Silver syndrome), 520004595$Spinal muscular atrophy, distal, type V]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000362$congenital generalized lipodystrophy, 790000430$diabetes mellitus, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000675$hereditary spastic paraplegia, 790000919$membrane, 790001015$neurodegeneration, 790001555$transmembrane]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),UP_SEQ_FEATURE[850059230$chain:Seipin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),INTERPRO[450003320$IPR003780:Cytochrome oxidase assembly]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038802$hsa00860:Porphyrin and chlorophyll metabolism]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),OMIM_DISEASE[520000810$Cardiomyopathy, hypertrophic, early-onset fatal, 520002807$Leigh syndrome due to cytochrome c oxidase deficiency]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),UP_SEQ_FEATURE[850013512$chain:Cytochrome c oxidase assembly protein COX15 homolog, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,INTERPRO[450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001331$ribosome biogenesis, 790001339$rna-binding, 790001345$rrna processing]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,UP_SEQ_FEATURE[850041119$chain:Probable ATP-dependent RNA helicase DDX56, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DENN/MADD domain containing 2C,INTERPRO[450001049$IPR001194:DENN, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 2C,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 2C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
DENN/MADD domain containing 2C,UP_SEQ_FEATURE[850014829$chain:DENN domain-containing protein 2C, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),INTERPRO[450001128$IPR001279:Beta-lactamase-like, 450010027$IPR011084:DNA repair metallo-beta-lactamase]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),UP_SEQ_FEATURE[850015510$chain:DNA cross-link repair 1B protein, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000084$h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N, 450013753$IPR015311:Apoptosis, DNA fragmentation factor 40 kDa]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SMART[760000238$SM00266:CAD]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),UP_SEQ_FEATURE[850015551$chain:DNA fragmentation factor subunit beta, 850103367$domain:CIDE-N, 850105852$helix, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
EF-hand calcium binding domain 4A,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450016534$IPR018249:EF-HAND 2]
EF-hand calcium binding domain 4A,SMART[760000046$SM00054:EFh]
EF-hand calcium binding domain 4A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
EF-hand calcium binding domain 4A,UP_SEQ_FEATURE[850016945$chain:EF-hand calcium-binding domain-containing protein 4A, 850102404$compositionally biased region:Arg-rich, 850102507$compositionally biased region:Glu-rich, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850117295$sequence variant, 850118574$splice variant]
FIG4 homolog (S. cerevisiae),INTERPRO[450001784$IPR002013:Synaptojanin, N-terminal]
FIG4 homolog (S. cerevisiae),OMIM_DISEASE[520000280$Amyotrophic lateral sclerosis 11, 520000969$Charcot-Marie-Tooth disease, type 4J]
FIG4 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000080$amyotrophic lateral sclerosis, 790000289$charcot-marie-tooth disease, 790000356$complete proteome, 790000446$disease mutation, 790000501$endosome, 790000743$hydrolase, 790000919$membrane, 790001015$neurodegeneration, 790001020$neuropathy, 790001212$polymorphism]
FIG4 homolog (S. cerevisiae),UP_SEQ_FEATURE[850039945$chain:Polyphosphoinositide phosphatase, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850105248$domain:SAC, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
FXYD domain containing ion transport regulator 2,BIOCARTA[30000023$h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2]
FXYD domain containing ion transport regulator 2,INTERPRO[450000237$IPR000272:Ion-transport regulator, FXYD region]
FXYD domain containing ion transport regulator 2,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction]
FXYD domain containing ion transport regulator 2,OMIM_DISEASE[520002525$Hypomagnesemia-2, renal]
FXYD domain containing ion transport regulator 2,PIR_SUPERFAMILY[630021015$PIRSF027828:PIRSF027828]
FXYD domain containing ion transport regulator 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000798$ion transport, 790000919$membrane, 790001226$potassium, 790001229$potassium transport, 790001240$primary hypomagnesemia, 790001418$Sodium, 790001421$Sodium transport, 790001422$sodium/potassium transport, 790001555$transmembrane, 790001558$transport]
FXYD domain containing ion transport regulator 2,UP_SEQ_FEATURE[850061295$chain:Sodium/potassium-transporting ATPase subunit gamma, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
FYN binding protein (FYB-120/130),INTERPRO[450001294$IPR001452:Src homology-3 domain, 450010373$IPR011511:Variant SH3, 450016415$IPR018115:Xylose isomerase, active site]
FYN binding protein (FYB-120/130),SMART[760000295$SM00326:SH3]
FYN binding protein (FYB-120/130),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
FYN binding protein (FYB-120/130),UP_SEQ_FEATURE[850020201$chain:FYN-binding protein, 850102580$compositionally biased region:Poly-Pro, 850105350$domain:SH3, 850105852$helix, 850106258$modified residue, 850112832$region of interest:Interaction with SKAP1, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117706$short sequence motif:SH2-binding, 850117709$short sequence motif:SH2-binding; to FYN, 850117710$short sequence motif:SH2-binding; to LCP2, 850118575$strand, 850118624$turn]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),BBID[10000076$56.Macrophage_regulation_of_CD4+T_cells]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038916$hsa05322:Systemic lupus erythematosus]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),OMIM_DISEASE[520002972$Lupus erythematosus, systemic, susceptibility, 520003622$Neutropenia, alloimmune neonatal, 520005034$Viral infections, recurrent]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),PIR_SUPERFAMILY[630002118$PIRSF001980:Fc gamma receptor III]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SMART[760000357$SM00409:IG]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000761$igg-binding protein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),UP_SEQ_FEATURE[850029060$chain:Low affinity immunoglobulin gamma Fc region receptor III-A, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
IKAROS family zinc finger 1 (Ikaros),COG_ONTOLOGY[90000073$General function prediction only]
IKAROS family zinc finger 1 (Ikaros),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
IKAROS family zinc finger 1 (Ikaros),OMIM_DISEASE[520002832$Leukemia, acute lymphoblastic]
IKAROS family zinc finger 1 (Ikaros),SMART[760000323$SM00355:ZnF_C2H2]
IKAROS family zinc finger 1 (Ikaros),SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000258$cell cycle, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
IKAROS family zinc finger 1 (Ikaros),UP_SEQ_FEATURE[850015926$chain:DNA-binding protein Ikaros, 850102576$compositionally biased region:Poly-Leu, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850114251$region of interest:Required for binding PP1CC, 850114261$region of interest:Required for both high-affinity DNA binding and pericentromeric heterochromatin localization, 850117294$sequence conflict, 850118520$site:Required for both pericentromeric heterochromatin localization and complete DNA binding, 850118521$site:Required for both pericentromeric heterochromatin localization and DNA binding, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
IQ motif and Sec7 domain 2,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450000787$IPR000904:SEC7-like, 450001635$IPR001849:Pleckstrin homology]
IQ motif and Sec7 domain 2,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
IQ motif and Sec7 domain 2,SMART[760000009$SM00015:IQ, 760000194$SM00222:Sec7, 760000205$SM00233:PH]
IQ motif and Sec7 domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
IQ motif and Sec7 domain 2,UP_SEQ_FEATURE[850026751$chain:IQ motif and SEC7 domain-containing protein 2, 850102540$compositionally biased region:His-rich, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850104439$domain:IQ, 850104979$domain:PH, 850105336$domain:SEC7, 850106258$modified residue, 850118574$splice variant]
KIAA0284,INTERPRO[450000219$IPR000253:Forkhead-associated]
KIAA0284,SMART[760000212$SM00240:FHA]
KIAA0284,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000811$isopeptide bond, 790000960$microtubule, 790001162$phosphoprotein, 790001592$ubl conjugation]
KIAA0284,UP_SEQ_FEATURE[850046544$chain:Protein KIAA0284, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103775$domain:FHA, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
KIAA1128,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like]
KIAA1128,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1128,UP_SEQ_FEATURE[850045936$chain:Protein FAM190B, 850102540$compositionally biased region:His-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KIAA1274,SP_PIR_KEYWORDS[790000356$complete proteome, 790000881$lipoprotein, 790001004$myristate, 790001212$polymorphism]
KIAA1274,UP_SEQ_FEATURE[850036738$chain:Paladin, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850117295$sequence variant]
Kv channel interacting protein 2,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
Kv channel interacting protein 2,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
Kv channel interacting protein 2,SMART[760000046$SM00054:EFh]
Kv channel interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001304$repeat, 790001558$transport, 790001631$voltage-gated channel]
Kv channel interacting protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850027659$chain:Kv channel-interacting protein 2, 850103582$domain:EF-hand 1; degenerate, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112463$region of interest:Interaction with KCND2, 850117294$sequence conflict, 850118574$splice variant]
M-phase phosphoprotein 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
M-phase phosphoprotein 9,UP_SEQ_FEATURE[850029453$chain:M-phase phosphoprotein 9, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MAS-related GPR, member F,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
MAS-related GPR, member F,PIR_SUPERFAMILY[630001858$PIRSF001712:mas-related G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
MAS-related GPR, member F,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
MAS-related GPR, member F,UP_SEQ_FEATURE[850030541$chain:Mas-related G-protein coupled receptor member F, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
N-terminal asparagine amidase,PIR_SUPERFAMILY[630019060$PIRSF023959:N-terminal asparagine amidohydrolase]
N-terminal asparagine amidase,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001212$polymorphism]
N-terminal asparagine amidase,UP_SEQ_FEATURE[850046976$chain:Protein N-terminal asparagine amidohydrolase, 850117295$sequence variant]
NmrA-like family domain containing 1,INTERPRO[450007368$IPR008030:NmrA-like, 450014426$IPR016040:NAD(P)-binding domain]
NmrA-like family domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000447$disulfide bond, 790001065$nucleus, 790001212$polymorphism]
NmrA-like family domain containing 1,UP_SEQ_FEATURE[850000461$binding site:NADP, 850000462$binding site:NADP; shared with dimeric partner, 850034468$chain:NmrA-like family domain-containing protein 1, 850102883$disulfide bond, 850105852$helix, 850106259$mutagenesis site, 850106307$nucleotide phosphate-binding region:NADP, 850112101$region of interest:Interaction with ASS1, 850117295$sequence variant, 850118575$strand, 850118624$turn]
OTU domain containing 7B,INTERPRO[450002353$IPR002653:Zinc finger, A20-type, 450002899$IPR003323:Ovarian tumour, otubain]
OTU domain containing 7B,SMART[760000231$SM00259:ZnF_A20]
OTU domain containing 7B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
OTU domain containing 7B,UP_SEQ_FEATURE[850036306$chain:OTU domain-containing protein 7B, 850104870$domain:OTU, 850106258$modified residue, 850106259$mutagenesis site, 850111190$region of interest:Catalytic, 850114894$region of interest:TRAF-binding, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118625$zinc finger region:A20-type]
PR domain containing 2, with ZNF domain,INTERPRO[450001068$IPR001214:SET, 450006475$IPR007087:Zinc finger, C2H2-type, 450008289$IPR009170:Predicted retinoblastoma binding protein (RIZ), 450014303$IPR015880:Zinc finger, C2H2-like]
PR domain containing 2, with ZNF domain,PIR_SUPERFAMILY[630002513$PIRSF002395:retinoblastoma binding protein (RIZ), 630002514$PIRSF002395:RIZ_SET]
PR domain containing 2, with ZNF domain,SMART[760000286$SM00317:SET, 760000323$SM00355:ZnF_C2H2]
PR domain containing 2, with ZNF domain,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000050$alternative initiation, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
PR domain containing 2, with ZNF domain,UP_SEQ_FEATURE[850040292$chain:PR domain zinc finger protein 2, 850102434$compositionally biased region:Arg/Lys-rich (basic), 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850105340$domain:SET, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114517$region of interest:Retinoblastoma protein binding, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118732$zinc finger region:C2H2-type 7; atypical, 850118735$zinc finger region:C2H2-type 8; atypical]
Purkinje cell protein 2,INTERPRO[450002733$IPR003109:GoLoco motif]
Purkinje cell protein 2,SMART[760000342$SM00390:GoLoco]
Purkinje cell protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001304$repeat]
Purkinje cell protein 2,UP_SEQ_FEATURE[850048972$chain:Purkinje cell protein 2 homolog, 850104071$domain:GoLoco 1, 850104072$domain:GoLoco 2]
Putative PRAME family member 24; PRAME family member 8,PIR_SUPERFAMILY[630029880$PIRSF038286:preferentially expressed antigen of melanoma (PRAME) family protein]
Putative PRAME family member 24; PRAME family member 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790000853$leucine-rich repeat, 790001304$repeat]
Putative PRAME family member 24; PRAME family member 8,UP_SEQ_FEATURE[850040344$chain:PRAME family member 8, 850053795$chain:Putative PRAME family member 24, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3]
RNA binding motif protein 17,INTERPRO[450000396$IPR000467:D111/G-patch, 450000430$IPR000504:RNA recognition motif, RNP-1, 450003478$IPR003954:RNA recognition, region 1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450015287$IPR016967:Splicing factor, SPF45]
RNA binding motif protein 17,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
RNA binding motif protein 17,PIR_SUPERFAMILY[630023617$PIRSF031066:splicing factor, SPF45 type, 630023618$PIRSF031066:Splicing_factor_SPF45]
RNA binding motif protein 17,SMART[760000328$SM00360:RRM, 760000329$SM00361:RRM_1, 760000389$SM00443:G_patch]
RNA binding motif protein 17,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding, 790001433$Spliceosome]
RNA binding motif protein 17,UP_SEQ_FEATURE[850062049$chain:Splicing factor 45, 850104022$domain:G-patch, 850105211$domain:RRM, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
RNA binding motif protein 6,COG_ONTOLOGY[90000070$Function unknown]
RNA binding motif protein 6,INTERPRO[450000396$IPR000467:D111/G-patch, 450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014303$IPR015880:Zinc finger, C2H2-like]
RNA binding motif protein 6,SMART[760000323$SM00355:ZnF_C2H2, 760000328$SM00360:RRM, 760000389$SM00443:G_patch]
RNA binding motif protein 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
RNA binding motif protein 6,UP_SEQ_FEATURE[850058503$chain:RNA-binding protein 6, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850104022$domain:G-patch, 850105211$domain:RRM, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
Rh blood group, CcEe antigens,INTERPRO[450001687$IPR001905:Ammonium transporter, 450001976$IPR002229:Blood group Rhesus C/E and D polypeptide]
Rh blood group, CcEe antigens,OMIM_DISEASE[520000615$Blood group, Rhesus, 520004327$Rh-null disease, amorph type]
Rh blood group, CcEe antigens,PIR_SUPERFAMILY[630014625$PIRSF017968:erythrocyte membrane protein RhD]
Rh blood group, CcEe antigens,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000194$blood group antigen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000512$erythrocyte, 790000919$membrane, 790001212$polymorphism, 790001469$surface antigen, 790001555$transmembrane, 790001556$transmembrane protein]
Rh blood group, CcEe antigens,UP_SEQ_FEATURE[850008177$chain:Blood group Rh(CE) polypeptide, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
Rho-related BTB domain containing 1,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450012373$IPR013753:Ras]
Rho-related BTB domain containing 1,PIR_SUPERFAMILY[630030010$PIRSF038482:Rho-related BTB domain-containing protein]
Rho-related BTB domain containing 1,SMART[760000148$SM00174:RHO, 760000197$SM00225:BTB]
Rho-related BTB domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001304$repeat]
Rho-related BTB domain containing 1,UP_SEQ_FEATURE[850057593$chain:Rho-related BTB domain-containing protein 1, 850103178$domain:BTB 1, 850103179$domain:BTB 2, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850114526$region of interest:Rho-like]
SEC14-like 3 (S. cerevisiae),INTERPRO[450000939$IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport, 450001103$IPR001251:Cellular retinaldehyde-binding/triple function, C-terminal, 450007565$IPR008273:Cellular retinaldehyde-binding/triple function, N-terminal, 450008192$IPR009038:GOLD]
SEC14-like 3 (S. cerevisiae),SMART[760000458$SM00516:SEC14]
SEC14-like 3 (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000876$lipid-binding, 790001212$polymorphism, 790001558$transport]
SEC14-like 3 (S. cerevisiae),UP_SEQ_FEATURE[850059083$chain:SEC14-like protein 3, 850103410$domain:CRAL-TRIO, 850104069$domain:GOLD, 850117295$sequence variant]
SET domain containing 2,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450001068$IPR001214:SET, 450003176$IPR003616:Post-SET zinc-binding region, 450005980$IPR006560:AWS, 450013566$IPR015119:Set2-Rpb1 interacting]
SET domain containing 2,KEGG_PATHWAY[470038751$hsa00310:Lysine degradation]
SET domain containing 2,SMART[760000286$SM00317:SET, 760000401$SM00456:WW, 760000451$SM00508:PostSET, 760000507$SM00570:AWS]
SET domain containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790000953$methylation, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase]
SET domain containing 2,UP_SEQ_FEATURE[850024164$chain:Histone-lysine N-methyltransferase SETD2, 850102404$compositionally biased region:Arg-rich, 850102485$compositionally biased region:Gln-rich, 850102586$compositionally biased region:Pro-rich, 850103074$domain:AWS, 850105053$domain:Post-SET, 850105340$domain:SET, 850105731$domain:WW, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112689$region of interest:Interaction with POLR2A, 850113304$region of interest:Low charge region, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450006446$IPR007052:CS domain, 450007054$IPR007699:SGS, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450015774$IPR017447:CS, 450017972$IPR019734:Tetratricopeptide repeat]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),PIR_SUPERFAMILY[630028306$PIRSF036827:PIRSF036827]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),SMART[760000020$SM00028:TPR]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat, 790001593$ubl conjugation pathway]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),UP_SEQ_FEATURE[850062991$chain:Suppressor of G2 allele of SKP1 homolog, 850103417$domain:CS, 850105345$domain:SGS, 850105852$helix, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
SH2 domain containing 1B,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain containing 1B,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity]
SH2 domain containing 1B,PIR_SUPERFAMILY[630029284$PIRSF037711:SH2 domain protein 1B]
SH2 domain containing 1B,SMART[760000224$SM00252:SH2]
SH2 domain containing 1B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001397$SH2 domain]
SH2 domain containing 1B,UP_SEQ_FEATURE[850060510$chain:SH2 domain-containing protein 1B, 850105346$domain:SH2, 850117295$sequence variant, 850118574$splice variant]
SH2 domain containing 4B,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain containing 4B,SMART[760000224$SM00252:SH2]
SH2 domain containing 4B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001397$SH2 domain]
SH2 domain containing 4B,UP_SEQ_FEATURE[850060515$chain:SH2 domain-containing protein 4B, 850102507$compositionally biased region:Glu-rich, 850105346$domain:SH2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SH2B adaptor protein 3,INTERPRO[450000852$IPR000980:SH2 motif, 450001635$IPR001849:Pleckstrin homology, 450013461$IPR015012:Phenylalanine zipper]
SH2B adaptor protein 3,KEGG_PATHWAY[470038877$hsa04722:Neurotrophin signaling pathway]
SH2B adaptor protein 3,OMIM_DISEASE[520000886$Celiac disease, susceptiblity to, 13, 520001490$Diabetes mellitus, insulin-dependent, susceptibility to, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520003637$Newly identified genetic risk variants for celiac disease related to the immune response]
SH2B adaptor protein 3,SMART[760000205$SM00233:PH, 760000224$SM00252:SH2]
SH2B adaptor protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000430$diabetes mellitus, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain]
SH2B adaptor protein 3,UP_SEQ_FEATURE[850060521$chain:SH2B adapter protein 3, 850104979$domain:PH, 850105346$domain:SH2, 850117294$sequence conflict, 850117295$sequence variant]
SNW domain containing 1,BIOCARTA[30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
SNW domain containing 1,INTERPRO[450003535$IPR004015:SKI-interacting protein SKIP, SNW domain, 450016181$IPR017862:SKI-interacting protein, SKIP]
SNW domain containing 1,KEGG_PATHWAY[470038818$hsa03040:Spliceosome, 470038848$hsa04330:Notch signaling pathway]
SNW domain containing 1,PIR_SUPERFAMILY[630012767$PIRSF015989:Caenorhabditis elegans hypothetical protein T27F2.1]
SNW domain containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001301$receptor, 790001433$Spliceosome]
SNW domain containing 1,UP_SEQ_FEATURE[850061161$chain:SNW domain-containing protein 1, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850114680$region of interest:SNW]
SPARC related modular calcium binding 2,INTERPRO[450000615$IPR000716:Thyroglobulin type-1, 450001814$IPR002048:Calcium-binding EF-hand, 450002091$IPR002350:Proteinase inhibitor I1, Kazal, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2, 450017814$IPR019577:SPARC/Testican, calcium-binding domain]
SPARC related modular calcium binding 2,SMART[760000046$SM00054:EFh, 760000184$SM00211:TY, 760000251$SM00280:KAZAL]
SPARC related modular calcium binding 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000171$basement membrane, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790001304$repeat, 790001363$Secreted, 790001405$signal]
SPARC related modular calcium binding 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850061581$chain:SPARC-related modular calcium-binding protein 2, 850102883$disulfide bond, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850104500$domain:Kazal-like, 850105486$domain:Thyroglobulin type-1 1, 850105489$domain:Thyroglobulin type-1 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
SRY (sex determining region Y)-box 9,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 9,OMIM_DISEASE[520000092$Acampomelic campomelic dysplasia, 520000736$Campomelic dysplasia, 520000737$Campomelic dysplasia with autosomal sex reversal]
SRY (sex determining region Y)-box 9,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 9,UP_SEQ_FEATURE[850065337$chain:Transcription factor SOX-9, 850102501$compositionally biased region:Gln/Pro-rich, 850102580$compositionally biased region:Poly-Pro, 850102920$DNA-binding region:HMG box, 850105852$helix, 850117295$sequence variant, 850118575$strand]
Sec61 alpha 2 subunit (S. cerevisiae),INTERPRO[450001958$IPR002208:SecY protein, 450017798$IPR019561:Translocon Sec61/SecY, plug domain]
Sec61 alpha 2 subunit (S. cerevisiae),KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
Sec61 alpha 2 subunit (S. cerevisiae),PIR_SUPERFAMILY[630004530$PIRSF004557:preprotein translocase Sec, SecY/Sec61-alpha subunit, 630004531$PIRSF004557:SecY]
Sec61 alpha 2 subunit (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001266$protein transport, 790001554$translocation, 790001555$transmembrane, 790001558$transport]
Sec61 alpha 2 subunit (S. cerevisiae),UP_SEQ_FEATURE[850048128$chain:Protein transport protein Sec61 subunit alpha isoform 2, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
TBC1 domain family, member 7,COG_ONTOLOGY[90000073$General function prediction only]
TBC1 domain family, member 7,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 7,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
TBC1 domain family, member 7,UP_SEQ_FEATURE[850063679$chain:TBC1 domain family member 7, 850105135$domain:Rab-GAP TBC, 850117295$sequence variant]
TERF1 (TRF1)-interacting nuclear factor 2,OMIM_DISEASE[520001589$Dyskeratosis congenita, autosomal dominant, 520004324$Revesz syndrome]
TERF1 (TRF1)-interacting nuclear factor 2,PIR_SUPERFAMILY[630030271$PIRSF038821:TERF1-interacting nuclear factor 2 (TINF2)]
TERF1 (TRF1)-interacting nuclear factor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000315$chromosomal protein, 790000356$complete proteome, 790000446$disease mutation, 790000476$dyskeratosis congenita, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001494$telomere]
TERF1 (TRF1)-interacting nuclear factor 2,UP_SEQ_FEATURE[850063842$chain:TERF1-interacting nuclear factor 2, 850106258$modified residue, 850114863$region of interest:TERF1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,BIOCARTA[30000314$h_WNVpathway:West Nile Virus]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,COG_ONTOLOGY[90000073$General function prediction only]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SMART[760000328$SM00360:RRM]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,UP_SEQ_FEATURE[850035207$chain:Nucleolysin TIAR, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
TRAF-type zinc finger domain containing 1,INTERPRO[450014303$IPR015880:Zinc finger, C2H2-like]
TRAF-type zinc finger domain containing 1,OMIM_DISEASE[520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls]
TRAF-type zinc finger domain containing 1,SMART[760000323$SM00355:ZnF_C2H2]
TRAF-type zinc finger domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001648$zinc, 790001651$zinc-finger]
TRAF-type zinc finger domain containing 1,UP_SEQ_FEATURE[850064872$chain:TRAF-type zinc finger domain-containing protein 1, 850102572$compositionally biased region:Poly-Glu, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118936$zinc finger region:TRAF-type]
TRAF3 interacting protein 2,INTERPRO[450012192$IPR013568:SEFIR]
TRAF3 interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
TRAF3 interacting protein 2,UP_SEQ_FEATURE[850003830$chain:Adapter protein CIKS, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),INTERPRO[450000667$IPR000772:Ricin B lectin, 450001029$IPR001173:Glycosyl transferase, family 2]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),PIR_SUPERFAMILY[630005598$PIRSF005670:polypeptide N-acetylgalactosaminyltransferase]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),SMART[760000403$SM00458:RICIN]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000848$Lectin, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),UP_SEQ_FEATURE[850039925$chain:Polypeptide N- acetylgalactosaminyltransferase 2, 850039926$chain:Polypeptide N- acetylgalactosaminyltransferase 2 soluble form, 850102883$disulfide bond, 850105188$domain:Ricin B-type lectin, 850105852$helix, 850111204$region of interest:Catalytic subdomain A, 850111205$region of interest:Catalytic subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118450$site:Not glycosylated, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118624$turn]
UEV and lactate/malate dehyrogenase domains,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450001087$IPR001236:Lactate/malate dehydrogenase, 450001383$IPR001557:L-lactate/malate dehydrogenase, 450008125$IPR008883:Tumour susceptibility gene 101, 450014366$IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal, 450014426$IPR016040:NAD(P)-binding domain, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
UEV and lactate/malate dehyrogenase domains,PIR_SUPERFAMILY[630000119$PIRSF000102:Lac_mal_DH]
UEV and lactate/malate dehyrogenase domains,SMART[760000185$SM00212:UBCc]
UEV and lactate/malate dehyrogenase domains,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001006$nad, 790001593$ubl conjugation pathway]
UEV and lactate/malate dehyrogenase domains,UP_SEQ_FEATURE[850068113$chain:Ubiquitin-conjugating enzyme E2 variant 3, 850105607$domain:UEV, 850105852$helix, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,INTERPRO[450000458$IPR000535:Major sperm protein, 450008175$IPR008962:PapD-like, 450015083$IPR016763:Vesicle-associated membrane protein]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,KEGG_PATHWAY[470038857$hsa04530:Tight junction]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,PIR_SUPERFAMILY[630016271$PIRSF019693:VAMP-associated]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,UP_SEQ_FEATURE[850100248$chain:Vesicle-associated membrane protein- associated protein A, 850104795$domain:MSP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,OMIM_DISEASE[520003613$Neuropathy, hereditary sensory and autonomic, type II, 520004158$Pseudohypoaldosteronism, type IIC]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,SP_PIR_KEYWORDS[790000052$alternative promoter usage, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001260$protein kinase inhibitor, 790001388$serine/threonine-protein kinase, 790001547$transferase]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850060062$chain:Serine/threonine-protein kinase WNK1, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
XRCC6 binding protein 1,INTERPRO[450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450017411$IPR019165:Peptidase M76, ATP23]
XRCC6 binding protein 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease]
XRCC6 binding protein 1,UP_SEQ_FEATURE[850031972$chain:Mitochondrial inner membrane protease ATP23 homolog, 850105995$metal ion-binding site:Divalent metal cation; catalytic, 850117295$sequence variant]
YME1-like 1 (S. cerevisiae),INTERPRO[450000549$IPR000642:Peptidase M41, 450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450005380$IPR005936:Peptidase M41, FtsH]
YME1-like 1 (S. cerevisiae),SMART[760000335$SM00382:AAA]
YME1-like 1 (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001252$Protease, 790001648$zinc]
YME1-like 1 (S. cerevisiae),UP_SEQ_FEATURE[850006648$chain:ATP-dependent metalloprotease YME1L1, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118574$splice variant]
abl-interactor 1,INTERPRO[450000090$IPR000108:Neutrophil cytosol factor 2, 450000626$IPR000727:Target SNARE coiled-coil region, 450001294$IPR001452:Src homology-3 domain, 450011527$IPR012849:Abl-interactor, homeo-domain homologous region]
abl-interactor 1,SMART[760000295$SM00326:SH3, 760000348$SM00397:t_SNARE]
abl-interactor 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000263$cell junction, 790000267$cell projection, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001475$synapse, 790001477$Synaptosome]
abl-interactor 1,UP_SEQ_FEATURE[850003175$chain:Abl interactor 1, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850105459$domain:t-SNARE coiled-coil homology, 850106258$modified residue, 850114260$region of interest:Required for binding to WASF1, 850117294$sequence conflict, 850117295$sequence variant, 850117890$site:Breakpoint for translocation to form MLL- ABI1, 850118574$splice variant]
acid phosphatase 6, lysophosphatidic,INTERPRO[450000480$IPR000560:Histidine acid phosphatase]
acid phosphatase 6, lysophosphatidic,KEGG_PATHWAY[470038794$hsa00740:Riboflavin metabolism]
acid phosphatase 6, lysophosphatidic,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
acid phosphatase 6, lysophosphatidic,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850029336$chain:Lysophosphatidic acid phosphatase type 6, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
actin related protein 2/3 complex, subunit 5-like,INTERPRO[450006195$IPR006789:ARP2/3 complex 16 kDa subunit (p16-Arc)]
actin related protein 2/3 complex, subunit 5-like,KEGG_PATHWAY[470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038898$hsa05130:Pathogenic Escherichia coli infection]
actin related protein 2/3 complex, subunit 5-like,PIR_SUPERFAMILY[630013130$PIRSF016358:Caenorhabditis elegans hypothetical protein M01B12.3]
actin related protein 2/3 complex, subunit 5-like,SP_PIR_KEYWORDS[790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001162$phosphoprotein]
actin related protein 2/3 complex, subunit 5-like,UP_SEQ_FEATURE[850003632$chain:Actin-related protein 2/3 complex subunit 5-like protein, 850106258$modified residue, 850117294$sequence conflict]
actin, alpha, cardiac muscle 1,INTERPRO[450003522$IPR004000:Actin/actin-like, 450003523$IPR004001:Actin, conserved site]
actin, alpha, cardiac muscle 1,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038922$hsa05414:Dilated cardiomyopathy]
actin, alpha, cardiac muscle 1,OMIM_DISEASE[520000450$Atrial septal defect 5, 520000780$Cardiomyopathy, dilated, 1R, 520000794$Cardiomyopathy, familial hypertrophic, 520000798$Cardiomyopathy, familial hypertrophic, 11]
actin, alpha, cardiac muscle 1,PIR_SUPERFAMILY[630002457$PIRSF002337:Actin]
actin, alpha, cardiac muscle 1,SMART[760000240$SM00268:ACTIN]
actin, alpha, cardiac muscle 1,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000012$acetylation, 790000138$atp-binding, 790000141$atrial septal defect, 790000244$cardiac muscle, 790000245$Cardiomyopathy, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000446$disease mutation, 790000646$heart, 790000950$methylated amino acid, 790000953$methylation, 790000996$muscle contraction, 790000997$muscle protein, 790001063$nucleotide-binding]
actin, alpha, cardiac muscle 1,UP_SEQ_FEATURE[850003516$chain:Actin, alpha cardiac muscle 1, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117295$sequence variant]
aldehyde dehydrogenase 6 family, member A1,INTERPRO[450009142$IPR010061:Methylmalonate-semialdehyde dehydrogenase, 450014029$IPR015590:Aldehyde dehydrogenase, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal]
aldehyde dehydrogenase 6 family, member A1,KEGG_PATHWAY[470038748$hsa00280:Valine, leucine and isoleucine degradation, 470038776$hsa00562:Inositol phosphate metabolism, 470038789$hsa00640:Propanoate metabolism]
aldehyde dehydrogenase 6 family, member A1,OMIM_DISEASE[520003265$Methylmalonate semialdehyde dehydrogenase deficiency]
aldehyde dehydrogenase 6 family, member A1,PIR_SUPERFAMILY[630000172$PIRSF000147:NAD-dependent aldehyde dehydrogenase]
aldehyde dehydrogenase 6 family, member A1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000446$disease mutation, 790000969$mitochondrion, 790001006$nad, 790001092$oxidoreductase, 790001550$transit peptide]
aldehyde dehydrogenase 6 family, member A1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000454$binding site:NAD, 850031529$chain:Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, 850106258$modified residue, 850106301$nucleotide phosphate-binding region:NAD, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
alpha- and gamma-adaptin-binding protein p34,INTERPRO[450017579$IPR019341:Alpha- and gamma-adaptin-binding protein p34]
alpha- and gamma-adaptin-binding protein p34,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
alpha- and gamma-adaptin-binding protein p34,UP_SEQ_FEATURE[850004580$chain:Alpha- and gamma-adaptin-binding protein p34, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
ankyrin repeat domain 12,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 12,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 12,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 12,UP_SEQ_FEATURE[850005362$chain:Ankyrin repeat domain-containing protein 12, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
aryl hydrocarbon receptor nuclear translocator-like 2,INTERPRO[450000012$IPR000014:PAS, 450000935$IPR001067:Nuclear translocator, 450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450001428$IPR001610:PAC motif, 450010429$IPR011598:Helix-loop-helix DNA-binding, 450012276$IPR013655:PAS fold-3, 450012386$IPR013767:PAS fold]
aryl hydrocarbon receptor nuclear translocator-like 2,SMART[760000074$SM00086:PAC, 760000079$SM00091:PAS, 760000321$SM00353:HLH]
aryl hydrocarbon receptor nuclear translocator-like 2,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000182$biological rhythms, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
aryl hydrocarbon receptor nuclear translocator-like 2,UP_SEQ_FEATURE[850006189$chain:Aryl hydrocarbon receptor nuclear translocator-like protein 2, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104880$domain:PAC, 850104897$domain:PAS 1, 850104898$domain:PAS 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
biogenesis of lysosomal organelles complex-1, subunit 2,INTERPRO[450017509$IPR019269:Biogenesis of lysosome-related organelles complex-1, subunit 2]
biogenesis of lysosomal organelles complex-1, subunit 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
biogenesis of lysosomal organelles complex-1, subunit 2,UP_SEQ_FEATURE[850008108$chain:Biogenesis of lysosome-related organelles complex 1 subunit 2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
calcium binding protein 2,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450014189$IPR015754:Calcium binding protein, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
calcium binding protein 2,SMART[760000046$SM00054:EFh]
calcium binding protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000624$golgi apparatus, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001304$repeat]
calcium binding protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850008971$chain:Calcium-binding protein 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850118574$splice variant]
calcium binding protein 39,INTERPRO[450012475$IPR013878:Mo25-like]
calcium binding protein 39,KEGG_PATHWAY[470038842$hsa04150:mTOR signaling pathway]
calcium binding protein 39,PIR_SUPERFAMILY[630008467$PIRSF009316:hypothetical protein, Saccharomyces cerevisiae YKL189w type]
calcium binding protein 39,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm]
calcium binding protein 39,UP_SEQ_FEATURE[850008973$chain:Calcium-binding protein 39, 850105852$helix, 850106258$modified residue, 850118624$turn]
calcium channel, voltage-dependent, beta 3 subunit,INTERPRO[450000497$IPR000584:Voltage-dependent calcium channel, L-type, beta subunit, 450001294$IPR001452:Src homology-3 domain, 450007416$IPR008079:Voltage-dependent calcium channel, L-type, beta-3 subunit, 450007478$IPR008145:Guanylate kinase/L-type calcium channel region]
calcium channel, voltage-dependent, beta 3 subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, beta 3 subunit,PIR_SUPERFAMILY[630012355$PIRSF015600:human voltage-dependent calcium channel beta chain]
calcium channel, voltage-dependent, beta 3 subunit,SMART[760000063$SM00072:GuKc, 760000295$SM00326:SH3]
calcium channel, voltage-dependent, beta 3 subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, beta 3 subunit,UP_SEQ_FEATURE[850100538$chain:Voltage-dependent L-type calcium channel subunit beta-3, 850105350$domain:SH3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calcium/calmodulin-dependent protein kinase II gamma,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000043$h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation, 30000070$h_crebPathway:Transcription factor CREB and its extracellular signals, 30000226$h_pgc1aPathway:Regulation of PGC-1a, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
calcium/calmodulin-dependent protein kinase II gamma,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450012167$IPR013543:Calcium/calmodulin dependent protein kinase II, association-domain, 450014177$IPR015742:Calcium/calmodulin-dependent protein kinase II isoform, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase II gamma,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038846$hsa04310:Wnt signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038879$hsa04740:Olfactory transduction, 470038883$hsa04912:GnRH signaling pathway, 470038885$hsa04916:Melanogenesis, 470038904$hsa05214:Glioma]
calcium/calmodulin-dependent protein kinase II gamma,PIR_SUPERFAMILY[630000701$PIRSF000594:calcium/calmodulin-dependent protein kinase II]
calcium/calmodulin-dependent protein kinase II gamma,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase II gamma,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase II gamma,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009093$chain:Calcium/calmodulin-dependent protein kinase type II subunit gamma, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111164$region of interest:Calmodulin-binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
capping protein (actin filament) muscle Z-line, alpha 1,INTERPRO[450001942$IPR002189:F-actin capping protein, alpha subunit, 450016184$IPR017865:F-actin capping protein, alpha subunit, conserved site, 450016599$IPR018315:F-actin capping protein, alpha subunit, actin binding]
capping protein (actin filament) muscle Z-line, alpha 1,PIR_SUPERFAMILY[630005921$PIRSF005982:actin-capping protein alpha chain]
capping protein (actin filament) muscle Z-line, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000018$actin capping, 790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing]
capping protein (actin filament) muscle Z-line, alpha 1,UP_SEQ_FEATURE[850018460$chain:F-actin-capping protein subunit alpha-1, 850106258$modified residue, 850117294$sequence conflict]
cell cycle exit and neuronal differentiation 1,PIR_SUPERFAMILY[630008836$PIRSF009834:pig BM88 antigen]
cell cycle exit and neuronal differentiation 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
cell cycle exit and neuronal differentiation 1,UP_SEQ_FEATURE[850010267$chain:Cell cycle exit and neuronal differentiation protein 1, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chemokine (C-X-C motif) ligand 2,INTERPRO[450000954$IPR001089:Small chemokine, C-X-C, 450001604$IPR001811:Small chemokine, interleukin-8-like, 450002193$IPR002473:Small chemokine, C-X-C/Interleukin 8, 450016352$IPR018048:Small chemokine, C-X-C, conserved site]
chemokine (C-X-C motif) ligand 2,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway]
chemokine (C-X-C motif) ligand 2,PIR_SUPERFAMILY[630002641$PIRSF002522:CXC chemokine, 630030765$PIRSF500568:growth regulated protein, alpha/beta/gamma types]
chemokine (C-X-C motif) ligand 2,SMART[760000172$SM00199:SCY]
chemokine (C-X-C motif) ligand 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000774$inflammation, 790000775$inflammatory response, 790001137$pharmaceutical, 790001363$Secreted, 790001405$signal]
chemokine (C-X-C motif) ligand 2,UP_SEQ_FEATURE[850008778$chain:C-X-C motif chemokine 2, 850022424$chain:GRO-beta(5-73), 850102883$disulfide bond, 850117814$signal peptide, 850118575$strand, 850118624$turn]
chloride channel 6,INTERPRO[450000551$IPR000644:Cystathionine beta-synthase, core, 450001600$IPR001807:Chloride channel, voltage gated, 450001994$IPR002248:Chloride channel CLC-6, 450013194$IPR014743:Chloride channel, core]
chloride channel 6,PIR_SUPERFAMILY[630012791$PIRSF016017:PIRSF016017]
chloride channel 6,SMART[760000103$SM00116:CBS]
chloride channel 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000102$antiport, 790000138$atp-binding, 790000255$CBS domain, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000501$endosome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
chloride channel 6,UP_SEQ_FEATURE[850000281$binding site:Chloride, 850000287$binding site:Chloride; via amide nitrogen, 850011091$chain:Chloride transport protein 6, 850102480$compositionally biased region:Cys-rich, 850103311$domain:CBS 1, 850103312$domain:CBS 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850112009$region of interest:In-membrane helix, 850112010$region of interest:In-membrane loop between two helices, 850117295$sequence variant, 850117701$short sequence motif:Selectivity filter part_1, 850117702$short sequence motif:Selectivity filter part_2, 850117703$short sequence motif:Selectivity filter part_3, 850118429$site:Mediates proton transfer from the outer aqueous phase to the interior of the protein; involved in linking H(+) and Cl(-) transport, 850118430$site:Mediates proton transfer from the protein to the inner aqueous phase, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
cholinergic receptor, muscarinic 1,BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation, 30000041$h_botulinPathway:Blockade of Neurotransmitter Relase by Botulinum Toxin, 30000204$h_no1Pathway:Actions of Nitric Oxide in the Heart, 30000304$h_tubbyPathway:G-Protein Signaling Through Tubby Proteins]
cholinergic receptor, muscarinic 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000866$IPR000995:Muscarinic acetylcholine receptor, 450001975$IPR002228:Muscarinic acetylcholine receptor M1, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
cholinergic receptor, muscarinic 1,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038881$hsa04810:Regulation of actin cytoskeleton]
cholinergic receptor, muscarinic 1,PIR_SUPERFAMILY[630030053$PIRSF038548:muscarinic acetylcholine receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
cholinergic receptor, muscarinic 1,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001026$neurotransmitter receptor, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001301$receptor, 790001475$synapse, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
cholinergic receptor, muscarinic 1,UP_SEQ_FEATURE[850032812$chain:Muscarinic acetylcholine receptor M1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromodomain helicase DNA binding protein 4,INTERPRO[450000283$IPR000330:SNF2-related, 450000831$IPR000953:Chromo domain, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450008565$IPR009462:Protein of unknown function DUF1086, 450008566$IPR009463:Protein of unknown function DUF1087, 450011633$IPR012957:CHD, C-terminal 2, 450011634$IPR012958:CHD, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
chromodomain helicase DNA binding protein 4,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000268$SM00298:CHROMO, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
chromodomain helicase DNA binding protein 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000311$chromatin regulator, 790000356$complete proteome, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
chromodomain helicase DNA binding protein 4,UP_SEQ_FEATURE[850011385$chain:Chromodomain-helicase-DNA-binding protein 4, 850102565$compositionally biased region:Poly-Ala, 850102568$compositionally biased region:Poly-Asp, 850102572$compositionally biased region:Poly-Glu, 850102576$compositionally biased region:Poly-Leu, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850103362$domain:Chromo 1, 850103363$domain:Chromo 2, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117387$short sequence motif:DEAH box, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
chromosome 1 open reading frame 130,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 1 open reading frame 130,UP_SEQ_FEATURE[850073591$chain:Uncharacterized protein C1orf130, 850102585$compositionally biased region:Poly-Val, 850118623$transmembrane region]
chromosome 1 open reading frame 85,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 1 open reading frame 85,UP_SEQ_FEATURE[850029379$chain:Lysosomal protein NCU-G1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chromosome 10 open reading frame 140,INTERPRO[450002951$IPR003380:Transforming protein Ski]
chromosome 10 open reading frame 140,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 10 open reading frame 140,UP_SEQ_FEATURE[850045618$chain:Protein DLN-1, 850102378$compositionally biased region:Ala-rich, 850102507$compositionally biased region:Glu-rich, 850102540$compositionally biased region:His-rich, 850102565$compositionally biased region:Poly-Ala, 850102597$compositionally biased region:Ser-rich, 850117294$sequence conflict]
chromosome 10 open reading frame 58; chromosome 10 open reading frame 57,PIR_SUPERFAMILY[630009558$PIRSF011010:Caenorhabditis elegans hypothetical protein R53.5]
chromosome 10 open reading frame 58; chromosome 10 open reading frame 57,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000919$membrane, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
chromosome 10 open reading frame 58; chromosome 10 open reading frame 57,UP_SEQ_FEATURE[850066251$chain:Transmembrane protein C10orf57, 850072908$chain:Uncharacterized protein C10orf58, 850117294$sequence conflict, 850117814$signal peptide, 850118623$transmembrane region]
chromosome 10 open reading frame 72,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450012396$IPR013783:Immunoglobulin-like fold]
chromosome 10 open reading frame 72,SMART[760000357$SM00409:IG]
chromosome 10 open reading frame 72,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 10 open reading frame 72,UP_SEQ_FEATURE[850069979$chain:Uncharacterized Ig-like domain-containing protein C10orf72, 850102883$disulfide bond, 850104199$domain:Ig-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 11 open reading frame 24,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 11 open reading frame 24,UP_SEQ_FEATURE[850072958$chain:Uncharacterized protein C11orf24, 850102586$compositionally biased region:Pro-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 12 open reading frame 30,INTERPRO[450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017429$IPR019183:N-acetyltransferase B complex, non-catalytic subunit]
chromosome 12 open reading frame 30,OMIM_DISEASE[520003249$Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci, 520004355$Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes]
chromosome 12 open reading frame 30,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
chromosome 12 open reading frame 30,UP_SEQ_FEATURE[850033292$chain:N-terminal acetyltransferase B complex subunit MDM20, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 14 open reading frame 45,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 14 open reading frame 45,UP_SEQ_FEATURE[850073188$chain:Uncharacterized protein C14orf45, 850106258$modified residue, 850117295$sequence variant]
chromosome 14 open reading frame 68,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
chromosome 14 open reading frame 68,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
chromosome 14 open reading frame 68,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
chromosome 14 open reading frame 68,UP_SEQ_FEATURE[850023492$chain:Hepatocellular carcinoma down-regulated mitochondrial carrier protein, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850118574$splice variant, 850118623$transmembrane region]
chromosome 15 open reading frame 60,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 15 open reading frame 60,UP_SEQ_FEATURE[850073239$chain:Uncharacterized protein C15orf60, 850117295$sequence variant]
chromosome 16 open reading frame 92,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 16 open reading frame 92,UP_SEQ_FEATURE[850073325$chain:Uncharacterized protein C16orf92, 850118574$splice variant, 850118623$transmembrane region]
chromosome 19 open reading frame 71,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 19 open reading frame 71,UP_SEQ_FEATURE[850073534$chain:Uncharacterized protein C19orf71, 850117295$sequence variant]
chromosome 2 open reading frame 14; Uncharacterized protein C2orf14-like 2; Uncharacterized protein C2orf14-like 1,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 2 open reading frame 14; Uncharacterized protein C2orf14-like 2; Uncharacterized protein C2orf14-like 1,UP_SEQ_FEATURE[850073927$chain:Uncharacterized protein C2orf14, 850073928$chain:Uncharacterized protein C2orf14-like 1, 850073929$chain:Uncharacterized protein C2orf14-like 2]
citron (rho-interacting, serine/threonine kinase 21),COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
citron (rho-interacting, serine/threonine kinase 21),INTERPRO[450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450001035$IPR001180:Citron-like, 450001635$IPR001849:Pleckstrin homology, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450002035$IPR002290:Serine/threonine protein kinase, 450004935$IPR005479:Carbamoyl phosphate synthetase, large subunit, ATP-binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450010818$IPR011993:Pleckstrin homology-type, 450015732$IPR017405:Citron Rho-interacting kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016207$IPR017892:Protein kinase, C-terminal]
citron (rho-interacting, serine/threonine kinase 21),PIR_SUPERFAMILY[630029748$PIRSF038145:citron Rho-interacting kinase, 630029749$PIRSF038145:Citron_Rho-interacting_kinase]
citron (rho-interacting, serine/threonine kinase 21),SMART[760000028$SM00036:CNH, 760000096$SM00109:C1, 760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000205$SM00233:PH]
citron (rho-interacting, serine/threonine kinase 21),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000825$kinase, 790000937$metal-binding, 790000973$mitosis, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001399$sh3-binding, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
citron (rho-interacting, serine/threonine kinase 21),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850011548$chain:Citron Rho-interacting kinase, 850103028$domain:AGC-kinase C-terminal, 850103376$domain:CNH, 850104979$domain:PH, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850112777$region of interest:Interaction with Rho/Rac, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant, 850118892$zinc finger region:Phorbol-ester/DAG-type]
clathrin, light chain (Lcb),INTERPRO[450000867$IPR000996:Clathrin light chain]
clathrin, light chain (Lcb),KEGG_PATHWAY[470038840$hsa04142:Lysosome, 470038841$hsa04144:Endocytosis, 470038894$hsa05016:Huntington's disease]
clathrin, light chain (Lcb),PIR_SUPERFAMILY[630002413$PIRSF002289:clathrin light chain]
clathrin, light chain (Lcb),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000334$coated pit, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000447$disulfide bond, 790000919$membrane, 790001162$phosphoprotein]
clathrin, light chain (Lcb),UP_SEQ_FEATURE[850011634$chain:Clathrin light chain B, 850102883$disulfide bond, 850106258$modified residue, 850113150$region of interest:Involved in binding clathrin heavy chain, 850117294$sequence conflict, 850118574$splice variant]
coiled-coil domain containing 38,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 38,UP_SEQ_FEATURE[850012007$chain:Coiled-coil domain-containing protein 38, 850117294$sequence conflict, 850117295$sequence variant]
coiled-coil domain containing 82,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 82,UP_SEQ_FEATURE[850012059$chain:Coiled-coil domain-containing protein 82, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
complement component 1, s subcomponent,BIOCARTA[30000066$h_classicPathway:Classical Complement Pathway, 30000067$h_compPathway:Complement Pathway]
complement component 1, s subcomponent,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000373$IPR000436:Sushi/SCR/CCP, 450000750$IPR000859:CUB, 450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450011699$IPR013032:EGF-like region, conserved site, 450014444$IPR016060:Complement control module, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
complement component 1, s subcomponent,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades, 470038916$hsa05322:Systemic lupus erythematosus]
complement component 1, s subcomponent,OMIM_DISEASE[520000719$C1r/C1s deficiency, combined, 520000720$C1s deficiency, isolated]
complement component 1, s subcomponent,PIR_SUPERFAMILY[630001305$PIRSF001155:complement-activating serine proteases C1r/C1s/MASP]
complement component 1, s subcomponent,SMART[760000013$SM00020:Tryp_SPc, 760000024$SM00032:CCP, 760000034$SM00042:CUB, 760000153$SM00179:EGF_CA]
complement component 1, s subcomponent,SP_PIR_KEYWORDS[790000002$3d-structure, 790000022$acute phase, 790000176$beta-hydroxyasparagine, 790000211$calcium, 790000212$calcium binding, 790000355$complement pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000481$egf-like domain, 790000616$glycoprotein, 790000701$homodimer, 790000743$hydrolase, 790000745$hydroxylation, 790000763$immune response, 790000777$innate immunity, 790000937$metal-binding, 790001191$plasma, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001471$sushi]
complement component 1, s subcomponent,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850012330$chain:Complement C1s subcomponent, 850012331$chain:Complement C1s subcomponent heavy chain, 850012332$chain:Complement C1s subcomponent light chain, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103705$domain:EGF-like; calcium-binding, 850104964$domain:Peptidase S1, 850105416$domain:Sushi 1, 850105429$domain:Sushi 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
coronin, actin binding protein, 2B,INTERPRO[450001490$IPR001680:WD40 repeat, 450013497$IPR015048:Region of unknown function DUF1899, 450013498$IPR015049:Region of unknown function DUF1900, 450013946$IPR015505:Coronin, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
coronin, actin binding protein, 2B,SMART[760000289$SM00320:WD40]
coronin, actin binding protein, 2B,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
coronin, actin binding protein, 2B,UP_SEQ_FEATURE[850012629$chain:Coronin-2B, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cubilin (intrinsic factor-cobalamin receptor),INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450000750$IPR000859:CUB, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
cubilin (intrinsic factor-cobalamin receptor),OMIM_DISEASE[520003120$Megaloblastic anemia-1, Finnish type]
cubilin (intrinsic factor-cobalamin receptor),PIR_SUPERFAMILY[630027753$PIRSF036316:intrinsic factor-B12 receptor cubilin]
cubilin (intrinsic factor-cobalamin receptor),SMART[760000034$SM00042:CUB, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
cubilin (intrinsic factor-cobalamin receptor),SP_PIR_KEYWORDS[790000211$calcium, 790000305$cholesterol metabolism, 790000329$cleavage on pair of basic residues, 790000336$Cobalamin, 790000338$cobalt, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000496$Endocytosis, 790000501$endosome, 790000616$glycoprotein, 790000873$lipid metabolism, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001442$steroid metabolism, 790001558$transport, 790001625$vitamin B12 uptake]
cubilin (intrinsic factor-cobalamin receptor),UP_SEQ_FEATURE[850012808$chain:Cubilin, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103434$domain:CUB 10, 850103435$domain:CUB 11, 850103436$domain:CUB 12, 850103437$domain:CUB 13, 850103438$domain:CUB 14, 850103439$domain:CUB 15, 850103440$domain:CUB 16, 850103441$domain:CUB 17, 850103442$domain:CUB 18, 850103443$domain:CUB 19, 850103444$domain:CUB 2, 850103445$domain:CUB 20, 850103446$domain:CUB 21, 850103447$domain:CUB 22, 850103448$domain:CUB 23, 850103449$domain:CUB 24, 850103450$domain:CUB 25, 850103451$domain:CUB 26, 850103452$domain:CUB 27, 850103453$domain:CUB 3, 850103454$domain:CUB 4, 850103455$domain:CUB 5, 850103456$domain:CUB 6, 850103457$domain:CUB 7, 850103458$domain:CUB 8, 850103459$domain:CUB 9, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103699$domain:EGF-like 7; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118052$site:Cleavage; by furin]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),BBID[10000001$1.RBphosphoE2F, 10000052$26.cyclin-CDK_complexes, 10000115$94.E2F_transcriptional_activity_cell_cycle]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),BIOCARTA[30000024$h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis, 30000059$h_cellcyclePathway:Cyclins and Cell Cycle Regulation, 30000074$h_ctcfPathway:CTCF: First Multivalent Nuclear Factor, 30000119$h_g1Pathway:Cell Cycle: G1/S Check Point ]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),INTERPRO[450001870$IPR002110:Ankyrin, 450009899$IPR010868:Cyclin-dependent kinase inhibitor 2a p19Arf, N-terminal]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038836$hsa04115:p53 signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038902$hsa05212:Pancreatic cancer, 470038904$hsa05214:Glioma, 470038908$hsa05218:Melanoma, 470038909$hsa05219:Bladder cancer, 470038910$hsa05220:Chronic myeloid leukemia, 470038913$hsa05223:Non-small cell lung cancer]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),OMIM_DISEASE[520000046$A common variant on chromosome 9p21 affects the risk of myocardial infarction, 520000069$A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants, 520001994$Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520002893$Li Fraumeni syndrome, 520003125$Melanoma and neural system tumor syndrome, 520003128$Melanoma, cutaneous malignant, 2, 520003247$Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes, 520003790$Orolaryngeal cancer, multiple, 520003890$Pancreatic cancer/melanoma syndrome, 520004728$Susceptibility loci for intracranial aneurysm in European and Japanese populations]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),PIR_SUPERFAMILY[630027780$PIRSF036346:cyclin-dependent kinase inhibitor p19]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),SMART[760000220$SM00248:ANK]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000109$Apoptosis, 790000258$cell cycle, 790000259$cell cycle control, 790000356$complete proteome, 790000389$cyclin, 790000407$cytoplasm, 790000446$disease mutation, 790000466$dna-binding, 790000825$kinase, 790000858$Li-Fraumeni syndrome, 790001065$nucleus, 790001212$polymorphism, 790001260$protein kinase inhibitor, 790001304$repeat, 790001345$rrna processing, 790001539$Transcription, 790001543$transcription regulation, 790001580$tumor suppressor]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),UP_SEQ_FEATURE[850013103$chain:Cyclin-dependent kinase inhibitor 2A, isoform 4, 850013105$chain:Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3, 850105852$helix, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cytochrome b, ascorbate dependent 3,INTERPRO[450004351$IPR004877:Cytochrome b561, eukaryote, 450006013$IPR006593:Cytochrome b561/ferric reductase transmembrane]
cytochrome b, ascorbate dependent 3,PIR_SUPERFAMILY[630013304$PIRSF016525:cytochrome b561]
cytochrome b, ascorbate dependent 3,SMART[760000578$SM00665:B561]
cytochrome b, ascorbate dependent 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000489$electron transport, 790000501$endosome, 790000616$glycoprotein, 790000652$heme, 790000802$iron, 790000897$lysosome, 790000919$membrane, 790000937$metal-binding, 790001092$oxidoreductase, 790001555$transmembrane, 790001558$transport]
cytochrome b, ascorbate dependent 3,UP_SEQ_FEATURE[850013429$chain:Cytochrome b ascorbate-dependent protein 3, 850103473$domain:Cytochrome b561, 850105770$glycosylation site:N-linked (GlcNAc...), 850106026$metal ion-binding site:Iron (heme axial ligand), 850117294$sequence conflict, 850118623$transmembrane region]
dachsous 1 (Drosophila),INTERPRO[450001884$IPR002126:Cadherin]
dachsous 1 (Drosophila),SMART[760000099$SM00112:CA]
dachsous 1 (Drosophila),SP_PIR_KEYWORDS[790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
dachsous 1 (Drosophila),UP_SEQ_FEATURE[850048752$chain:Protocadherin-16, 850103211$domain:Cadherin 1, 850103212$domain:Cadherin 10, 850103213$domain:Cadherin 11, 850103214$domain:Cadherin 12, 850103215$domain:Cadherin 13, 850103216$domain:Cadherin 14, 850103217$domain:Cadherin 15, 850103218$domain:Cadherin 16, 850103219$domain:Cadherin 17, 850103220$domain:Cadherin 18, 850103221$domain:Cadherin 19, 850103222$domain:Cadherin 2, 850103223$domain:Cadherin 20, 850103224$domain:Cadherin 21, 850103225$domain:Cadherin 22, 850103226$domain:Cadherin 23, 850103227$domain:Cadherin 24, 850103228$domain:Cadherin 25, 850103229$domain:Cadherin 26, 850103230$domain:Cadherin 27, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850103242$domain:Cadherin 7, 850103243$domain:Cadherin 8, 850103244$domain:Cadherin 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
death effector domain containing 2,INTERPRO[450001658$IPR001875:Death effector]
death effector domain containing 2,SMART[760000023$SM00031:DED]
death effector domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
death effector domain containing 2,UP_SEQ_FEATURE[850015883$chain:DNA-binding death effector domain- containing protein 2, 850103511$domain:DED, 850117294$sequence conflict, 850117325$short sequence motif:Bipartite nuclear localization signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
diablo homolog (Drosophila),BBID[10000023$126.Apoptosis-Bcl-2, 10000024$127.Mito-stress, 10000103$81.Structure_of_Caps_and_SMACs]
diablo homolog (Drosophila),BIOCARTA[30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling]
diablo homolog (Drosophila),INTERPRO[450013589$IPR015142:Second mitochondria-derived activator of caspase/Direct IAP-binding protein with low PI]
diablo homolog (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000969$mitochondrion, 790001550$transit peptide]
diablo homolog (Drosophila),UP_SEQ_FEATURE[850014989$chain:Diablo homolog, mitochondrial, 850105852$helix, 850117294$sequence conflict, 850117494$short sequence motif:IAP-binding, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation, 30000015$h_alkPathway:ALK in cardiac myocytes, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000137$h_hesPathway:Segmentation Clock, 30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2, 30000240$h_ps1Pathway:Presenilin action in Notch and Wnt signaling, 30000313$h_wntPathway:WNT Signaling Pathway]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,INTERPRO[450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450001015$IPR001158:DIX, 450001316$IPR001478:PDZ/DHR/GLGF, 450002925$IPR003351:Dishevelled protein, 450007617$IPR008339:Dishevelled region, 450007618$IPR008340:Dishevelled-1 protein, 450010816$IPR011991:Winged helix repressor DNA-binding, 450013947$IPR015506:Dishevelled related protein]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038848$hsa04330:Notch signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038907$hsa05217:Basal cell carcinoma]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,SMART[760000014$SM00021:DAX, 760000041$SM00049:DEP, 760000200$SM00228:PDZ]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790001162$phosphoprotein, 790001592$ubl conjugation, 790001642$wnt signaling pathway]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,UP_SEQ_FEATURE[850059217$chain:Segment polarity protein dishevelled homolog DVL-1, 850059218$chain:Segment polarity protein dishevelled homolog DVL-1-like, 850102566$compositionally biased region:Poly-Arg, 850103515$domain:DEP, 850103527$domain:DIX, 850104918$domain:PDZ, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),INTERPRO[450016755$IPR018481:Glycosyl transferase, family 4, conserved region]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),OMIM_DISEASE[520001181$Congenital disorder of glycosylation, type Ij]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),PIR_SUPERFAMILY[630006312$PIRSF006375:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000359$congenital disorder of glycosylation, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),UP_SEQ_FEATURE[850068279$chain:UDP-N-acetylglucosamine--dolichyl- phosphate N- acetylglucosaminephosphotransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117422$short sequence motif:Dolichol recognition, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
downstream neighbor of SON,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001065$nucleus, 790001162$phosphoprotein]
downstream neighbor of SON,UP_SEQ_FEATURE[850045640$chain:Protein downstream neighbor of Son, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
dystonin,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning, 90000057$DNA replication, recombination, and repair]
dystonin,INTERPRO[450000887$IPR001014:Ribosomal protein L23/L25, conserved site, 450000964$IPR001101:Plectin repeat, 450001411$IPR001589:Actinin-type, actin-binding, conserved site, 450001520$IPR001715:Calponin-like actin-binding, 450001788$IPR002017:Spectrin repeat, 450001814$IPR002048:Calcium-binding EF-hand, 450002732$IPR003108:Growth-arrest-specific protein 2, 450010817$IPR011992:EF-Hand type, 450016451$IPR018159:Spectrin/alpha-actinin, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
dystonin,PIR_SUPERFAMILY[630002765$PIRSF002662:plectin]
dystonin,SMART[760000025$SM00033:CH, 760000046$SM00054:EFh, 760000132$SM00150:SPEC, 760000215$SM00243:GAS2, 760000222$SM00250:PLEC]
dystonin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000053$alternative splicing, 790000171$basement membrane, 790000211$calcium, 790000256$cell adhesion, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000530$extracellular matrix, 790000616$glycoprotein, 790000811$isopeptide bond, 790000924$membrane protein, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain, 790001592$ubl conjugation]
dystonin,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850008525$chain:Bullous pemphigoid antigen 1, isoform 7, 850008527$chain:Bullous pemphigoid antigen 1, isoforms 1/2/3/4/5/8, 850008529$chain:Bullous pemphigoid antigen 1, isoforms 6/9/10, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103007$domain:Actin-binding, 850103318$domain:CH 1, 850103319$domain:CH 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105350$domain:SH3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111230$region of interest:Central fibrous rod domain, 850111755$region of interest:Globular 1, 850111756$region of interest:Globular 2, 850116729$repeat:Plectin 1, 850116730$repeat:Plectin 10, 850116731$repeat:Plectin 11, 850116740$repeat:Plectin 2, 850116751$repeat:Plectin 3, 850116762$repeat:Plectin 4, 850116773$repeat:Plectin 5, 850116784$repeat:Plectin 6, 850116795$repeat:Plectin 7, 850116803$repeat:Plectin 8, 850116804$repeat:Plectin 9, 850117015$repeat:Spectrin 1, 850117016$repeat:Spectrin 10, 850117017$repeat:Spectrin 11, 850117018$repeat:Spectrin 12, 850117019$repeat:Spectrin 13, 850117020$repeat:Spectrin 14, 850117021$repeat:Spectrin 15, 850117022$repeat:Spectrin 16, 850117023$repeat:Spectrin 17, 850117024$repeat:Spectrin 18, 850117025$repeat:Spectrin 19, 850117026$repeat:Spectrin 2, 850117027$repeat:Spectrin 20, 850117028$repeat:Spectrin 21, 850117029$repeat:Spectrin 22, 850117030$repeat:Spectrin 23, 850117031$repeat:Spectrin 24, 850117032$repeat:Spectrin 25, 850117033$repeat:Spectrin 26, 850117034$repeat:Spectrin 27, 850117035$repeat:Spectrin 28, 850117036$repeat:Spectrin 29, 850117037$repeat:Spectrin 3, 850117046$repeat:Spectrin 4, 850117047$repeat:Spectrin 5, 850117048$repeat:Spectrin 6, 850117049$repeat:Spectrin 7, 850117050$repeat:Spectrin 8, 850117051$repeat:Spectrin 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dystrobrevin, alpha,INTERPRO[450000371$IPR000433:Zinc finger, ZZ-type, 450010817$IPR011992:EF-Hand type, 450013600$IPR015153:EF-hand, region 1, 450013601$IPR015154:EF-hand, region 2, 450015760$IPR017432:Distrobrevin]
dystrobrevin, alpha,OMIM_DISEASE[520002801$Left ventricular noncompaction with congenital heart defects, 520002802$Left ventricular noncompaction, familial isolated, 1]
dystrobrevin, alpha,PIR_SUPERFAMILY[630029818$PIRSF038204:Distrobrevin]
dystrobrevin, alpha,SMART[760000262$SM00291:ZnF_ZZ]
dystrobrevin, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000937$metal-binding, 790001162$phosphoprotein, 790001475$synapse, 790001648$zinc, 790001651$zinc-finger]
dystrobrevin, alpha,UP_SEQ_FEATURE[850016560$chain:Dystrobrevin alpha, 850105852$helix, 850106258$modified residue, 850114839$region of interest:Syntrophin-binding region, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118951$zinc finger region:ZZ-type]
electron-transfer-flavoprotein, alpha polypeptide,COG_ONTOLOGY[90000064$Energy production and conversion]
electron-transfer-flavoprotein, alpha polypeptide,INTERPRO[450001152$IPR001308:Electron transfer flavoprotein, alpha subunit, 450013180$IPR014729:Rossmann-like alpha/beta/alpha sandwich fold, 450013181$IPR014730:Electron transfer flavoprotein, alpha/beta-subunit, N-terminal, 450013182$IPR014731:Electron transfer flavoprotein, alpha subunit, C-terminal, 450016493$IPR018206:Electron transfer flavoprotein, alpha subunit, C-terminal, conserved site]
electron-transfer-flavoprotein, alpha polypeptide,OMIM_DISEASE[520002133$Glutaricaciduria, type IIA]
electron-transfer-flavoprotein, alpha polypeptide,PIR_SUPERFAMILY[630000101$PIRSF000089:Electra_flavoP_a, 630000102$PIRSF000089:electron transfer flavoprotein, alpha subunit]
electron-transfer-flavoprotein, alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000489$electron transport, 790000537$FAD, 790000559$Flavoprotein, 790000601$Glutaricaciduria, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide, 790001558$transport]
electron-transfer-flavoprotein, alpha polypeptide,UP_SEQ_FEATURE[850017044$chain:Electron transfer flavoprotein subunit alpha, mitochondrial, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
epithelial splicing regulatory protein 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
epithelial splicing regulatory protein 1,SMART[760000328$SM00360:RRM]
epithelial splicing regulatory protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
epithelial splicing regulatory protein 1,UP_SEQ_FEATURE[850017707$chain:Epithelial splicing regulatory protein 1, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
etoposide induced 2.4 mRNA,INTERPRO[450008976$IPR009890:Etoposide-induced 2.4]
etoposide induced 2.4 mRNA,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
etoposide induced 2.4 mRNA,PIR_SUPERFAMILY[630029664$PIRSF038080:etoposide-induced protein 2.4]
etoposide induced 2.4 mRNA,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
etoposide induced 2.4 mRNA,UP_SEQ_FEATURE[850018033$chain:Etoposide-induced protein 2.4 homolog, 850102566$compositionally biased region:Poly-Arg, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
eukaryotic translation initiation factor 2-alpha kinase 2,BIOCARTA[30000094$h_eif2Pathway:Regulation of eIF2, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000250$h_ranklPathway:Bone Remodelling, 30000262$h_rnaPathway:Double Stranded RNA Induced Gene Expression, 30000300$h_tollPathway:Toll-Like Receptor Pathway]
eukaryotic translation initiation factor 2-alpha kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001016$IPR001159:Double-stranded RNA binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450013172$IPR014720:Double-stranded RNA-binding-like, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
eukaryotic translation initiation factor 2-alpha kinase 2,SMART[760000326$SM00358:DSRM]
eukaryotic translation initiation factor 2-alpha kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000104$Antiviral defense, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001388$serine/threonine-protein kinase, 790001547$transferase]
eukaryotic translation initiation factor 2-alpha kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850026469$chain:Interferon-induced, double-stranded RNA- activated protein kinase, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850109967$region of interest:2 X 13 AA approximate repeats, 850115074$repeat:1, 850115273$repeat:2, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
exocyst complex component 6,INTERPRO[450006595$IPR007225:Exocyst complex subunit Sec15-like]
exocyst complex component 6,PIR_SUPERFAMILY[630019487$PIRSF025007:exocyst complex, component Sec15, 630019488$PIRSF025007:Sec15]
exocyst complex component 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000522$exocytosis, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
exocyst complex component 6,UP_SEQ_FEATURE[850018194$chain:Exocyst complex component 6, 850117294$sequence conflict, 850117295$sequence variant]
exonuclease 3'-5' domain containing 2,INTERPRO[450002278$IPR002562:3'-5' exonuclease]
exonuclease 3'-5' domain containing 2,SMART[760000419$SM00474:35EXOc]
exonuclease 3'-5' domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism]
exonuclease 3'-5' domain containing 2,UP_SEQ_FEATURE[850018235$chain:Exonuclease 3'-5' domain-containing protein 2, 850102974$domain:3'-5' exonuclease, 850117294$sequence conflict, 850117295$sequence variant]
family with sequence similarity 116, member A,INTERPRO[450011538$IPR012860:Protein of unknown function DUF1630]
family with sequence similarity 116, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
family with sequence similarity 116, member A,UP_SEQ_FEATURE[850045838$chain:Protein FAM116A, 850106258$modified residue, 850117294$sequence conflict]
family with sequence similarity 155, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
family with sequence similarity 155, member A,UP_SEQ_FEATURE[850066307$chain:Transmembrane protein FAM155A, 850102570$compositionally biased region:Poly-Gln, 850102573$compositionally biased region:Poly-Gly, 850105770$glycosylation site:N-linked (GlcNAc...), 850118623$transmembrane region]
family with sequence similarity 160, member B1,INTERPRO[450017622$IPR019384:Retinoic acid induced 16-like protein]
family with sequence similarity 160, member B1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 160, member B1,UP_SEQ_FEATURE[850097667$chain:UPF0518 protein FAM160B1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 177, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 177, member B,UP_SEQ_FEATURE[850045907$chain:Protein FAM177B, 850102572$compositionally biased region:Poly-Glu, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 46, member B,INTERPRO[450011613$IPR012937:Protein of unknown function DUF1693]
family with sequence similarity 46, member B,PIR_SUPERFAMILY[630011340$PIRSF013835:Caenorhabditis elegans hypothetical protein F55A12.9]
family with sequence similarity 46, member B,SP_PIR_KEYWORDS[790000356$complete proteome]
family with sequence similarity 46, member B,UP_SEQ_FEATURE[850045989$chain:Protein FAM46B]
family with sequence similarity 54, member A,INTERPRO[450007315$IPR007972:Protein of unknown function DUF729]
family with sequence similarity 54, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 54, member A,UP_SEQ_FEATURE[850046007$chain:Protein FAM54A, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant]
family with sequence similarity 55, member B,OMIM_DISEASE[520000048$A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study]
family with sequence similarity 55, member B,PIR_SUPERFAMILY[630010122$PIRSF011875:pirsf011875]
family with sequence similarity 55, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 55, member B,UP_SEQ_FEATURE[850046012$chain:Protein FAM55B, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
fatty acid synthase,INTERPRO[450000688$IPR000794:Beta-ketoacyl synthase, 450000904$IPR001031:Thioesterase, 450001079$IPR001227:Acyl transferase region, 450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450005594$IPR006162:Phosphopantetheine attachment site, 450005595$IPR006163:Phosphopantetheine-binding, 450008211$IPR009081:Acyl carrier protein-like, 450011786$IPR013149:Alcohol dehydrogenase, zinc-binding, 450011854$IPR013217:Methyltransferase type 12, 450012624$IPR014030:Beta-ketoacyl synthase, N-terminal, 450012625$IPR014031:Beta-ketoacyl synthase, C-terminal, 450012635$IPR014043:Acyl transferase, 450014425$IPR016038:Thiolase-like, subgroup, 450014426$IPR016040:NAD(P)-binding domain, 450016488$IPR018201:Beta-ketoacyl synthase, active site]
fatty acid synthase,KEGG_PATHWAY[470038732$hsa00061:Fatty acid biosynthesis, 470038882$hsa04910:Insulin signaling pathway]
fatty acid synthase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000542$Fatty acid biosynthesis, 790000743$hydrolase, 790000874$lipid synthesis, 790000891$lyase, 790000993$multifunctional enzyme, 790001006$nad, 790001008$nadp, 790001092$oxidoreductase, 790001161$Phosphopantetheine, 790001162$phosphoprotein, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase]
fatty acid synthase,UP_SEQ_FEATURE[850000033$active site:For beta-hydroxyacyl dehydratase activity, 850000040$active site:For beta-ketoacyl synthase activity, 850000054$active site:For malonyltransferase activity, 850000083$active site:For thioesterase activity, 850019051$chain:Fatty acid synthase, 850103010$domain:Acyl carrier, 850105852$helix, 850106258$modified residue, 850106308$nucleotide phosphate-binding region:NADP (ER), 850106309$nucleotide phosphate-binding region:NADP (KR), 850110865$region of interest:Acyl and malonyl transferases, 850111013$region of interest:Beta-ketoacyl reductase, 850111016$region of interest:Beta-ketoacyl synthase, 850111587$region of interest:Enoyl reductase, 850114875$region of interest:Thioesterase, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
fibroblast growth factor 14,INTERPRO[450001959$IPR002209:Heparin-binding growth factor/Fibroblast growth factor, 450002089$IPR002348:Interleukin 1/heparin-binding growth factor]
fibroblast growth factor 14,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038899$hsa05200:Pathways in cancer, 470038908$hsa05218:Melanoma]
fibroblast growth factor 14,OMIM_DISEASE[520004635$Spinocerebellar ataxia-27]
fibroblast growth factor 14,SMART[760000388$SM00442:FGF]
fibroblast growth factor 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000632$growth factor, 790001015$neurodegeneration, 790001065$nucleus, 790001212$polymorphism, 790001431$spinocerebellar ataxia]
fibroblast growth factor 14,UP_SEQ_FEATURE[850019388$chain:Fibroblast growth factor 14, 850117295$sequence variant, 850118574$splice variant]
flavin containing monooxygenase 2 (non-functional),INTERPRO[450000835$IPR000960:Flavin-containing monooxygenase FMO, 450002000$IPR002254:Flavin-containing monooxygenase (FMO) 2, 450010924$IPR012143:Dimethylaniline monooxygenase, N-oxide-forming]
flavin containing monooxygenase 2 (non-functional),KEGG_PATHWAY[470038809$hsa00982:Drug metabolism]
flavin containing monooxygenase 2 (non-functional),PIR_SUPERFAMILY[630000386$PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming), 630000387$PIRSF000332:FMO]
flavin containing monooxygenase 2 (non-functional),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000899$magnesium, 790000919$membrane, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001555$transmembrane]
flavin containing monooxygenase 2 (non-functional),UP_SEQ_FEATURE[850015179$chain:Dimethylaniline monooxygenase [N-oxide- forming] 2, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant]
fms-related tyrosine kinase 3 ligand,INTERPRO[450003721$IPR004213:Flt3 ligand, 450011046$IPR012351:Four-helical cytokine, core]
fms-related tyrosine kinase 3 ligand,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038867$hsa04640:Hematopoietic cell lineage, 470038899$hsa05200:Pathways in cancer]
fms-related tyrosine kinase 3 ligand,PIR_SUPERFAMILY[630012510$PIRSF015744:Fms-related tyrosine kinase 3 ligand/SL cytokine]
fms-related tyrosine kinase 3 ligand,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
fms-related tyrosine kinase 3 ligand,UP_SEQ_FEATURE[850060940$chain:SL cytokine, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
forkhead box J2,INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box J2,SMART[760000307$SM00339:FH]
forkhead box J2,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
forkhead box J2,UP_SEQ_FEATURE[850019877$chain:Forkhead box protein J2, 850102570$compositionally biased region:Poly-Gln, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102914$DNA-binding region:Fork-head, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
gamma-glutamyl cyclotransferase,INTERPRO[450008399$IPR009288:AIG2-like, 450016251$IPR017939:Gamma-glutamylcyclotransferase]
gamma-glutamyl cyclotransferase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
gamma-glutamyl cyclotransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790001547$transferase]
gamma-glutamyl cyclotransferase,UP_SEQ_FEATURE[850020541$chain:Gamma-glutamylcyclotransferase, 850105852$helix, 850106259$mutagenesis site, 850118574$splice variant, 850118575$strand, 850118624$turn]
glucocorticoid modulatory element binding protein 1,INTERPRO[450000665$IPR000770:SAND, 450009947$IPR010919:SAND-like]
glucocorticoid modulatory element binding protein 1,SMART[760000230$SM00258:SAND]
glucocorticoid modulatory element binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc]
glucocorticoid modulatory element binding protein 1,UP_SEQ_FEATURE[850000333$binding site:DNA, 850021368$chain:Glucocorticoid modulatory element-binding protein 1, 850105253$domain:SAND, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
glutamate receptor, metabotropic 2,INTERPRO[450000138$IPR000162:GPCR, family 3, metabotropic glutamate receptor, 450000290$IPR000337:GPCR, family 3, 450001299$IPR001458:GPCR, family 3, metabotropic glutamate receptor 2, 450001618$IPR001828:Extracellular ligand-binding receptor, 450010362$IPR011500:GPCR, family 3, nine cysteines region, 450016286$IPR017978:GPCR, family 3, C-terminal, 450016287$IPR017979:GPCR, family 3, conserved site]
glutamate receptor, metabotropic 2,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
glutamate receptor, metabotropic 2,PIR_SUPERFAMILY[630005529$PIRSF005608:metabotropic glutamate receptors and related]
glutamate receptor, metabotropic 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
glutamate receptor, metabotropic 2,UP_SEQ_FEATURE[850031237$chain:Metabotropic glutamate receptor 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glutathione S-transferase mu 2 (muscle),COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
glutathione S-transferase mu 2 (muscle),INTERPRO[450002707$IPR003081:Glutathione S-transferase, Mu class, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase mu 2 (muscle),KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase mu 2 (muscle),PIR_SUPERFAMILY[630000598$PIRSF000503:glutathione transferase]
glutathione S-transferase mu 2 (muscle),SP_PIR_KEYWORDS[790000002$3d-structure, 790000199$brain, 790000244$cardiac muscle, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000646$heart, 790000701$homodimer, 790001212$polymorphism, 790001415$skeletal muscle, 790001547$transferase]
glutathione S-transferase mu 2 (muscle),UP_SEQ_FEATURE[850021801$chain:Glutathione S-transferase Mu 2, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
glutathione synthetase,BIOCARTA[30000117$h_freePathway:Free Radical Induced Apoptosis]
glutathione synthetase,INTERPRO[450004360$IPR004887:Glutathione synthase, substrate-binding, eukaryotic, 450005064$IPR005615:Glutathione synthase, eukaryotic, 450012420$IPR013816:ATP-grasp fold, subdomain 2, 450012634$IPR014042:Glutathione synthase, alpha-helical, eukaryotic, 450012641$IPR014049:Glutathione synthase, N-terminal, eukaryotic]
glutathione synthetase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
glutathione synthetase,OMIM_DISEASE[520002136$Glutathione synthetase deficiency, 520002266$Hemolytic anemia due to glutathione synthetase deficiency]
glutathione synthetase,PIR_SUPERFAMILY[630001728$PIRSF001558:glutathione synthase, 630001729$PIRSF001558:GSHase]
glutathione synthetase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000603$glutathione biosynthesis, 790000672$hereditary hemolytic anemia, 790000859$ligase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
glutathione synthetase,UP_SEQ_FEATURE[850000242$binding site:ATP, 850000249$binding site:ATP; via carbonyl oxygen, 850000555$binding site:Substrate, 850021826$chain:Glutathione synthetase, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
growth differentiation factor 15,INTERPRO[450001626$IPR001839:Transforming growth factor beta, 450016259$IPR017948:Transforming growth factor beta, conserved site]
growth differentiation factor 15,SMART[760000177$SM00204:TGFB]
growth differentiation factor 15,SP_PIR_KEYWORDS[790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000632$growth factor, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
growth differentiation factor 15,UP_SEQ_FEATURE[850022489$chain:Growth/differentiation factor 15, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
hect domain and RLD 2,COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton]
hect domain and RLD 2,INTERPRO[450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450000371$IPR000433:Zinc finger, ZZ-type, 450000485$IPR000569:HECT, 450001053$IPR001199:Cytochrome b5, 450004408$IPR004939:Anaphase-promoting complex, subunit 10, 450006043$IPR006624:Beta-propeller repeat TECPR, 450008218$IPR009091:Regulator of chromosome condensation/beta-lactamase-inhibitor protein II, 450009656$IPR010606:Mib-herc2, 450016778$IPR018506:Cytochrome b5, heme-binding site, 450018010$IPR019775:WD40 repeat, conserved site]
hect domain and RLD 2,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
hect domain and RLD 2,OMIM_DISEASE[520000057$A Genome-Wide Association Study Identifies Novel Alleles Associated with Hair Color and Skin Pigmentation, 520004495$Skin/hair/eye pigmentation 1, blond/brown hair, 520004496$Skin/hair/eye pigmentation 1, blue/nonblue eyes, 520004821$Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene]
hect domain and RLD 2,SMART[760000104$SM00119:HECTc, 760000262$SM00291:ZnF_ZZ, 760000613$SM00706:TECPR]
hect domain and RLD 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000344$coiled coil, 790000356$complete proteome, 790000859$ligase, 790000937$metal-binding, 790001162$phosphoprotein, 790001304$repeat, 790001593$ubl conjugation pathway, 790001638$wd repeat, 790001648$zinc, 790001651$zinc-finger]
hect domain and RLD 2,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850041853$chain:Probable E3 ubiquitin-protein ligase HERC2, 850103472$domain:Cytochrome b5 heme-binding, 850103533$domain:DOC, 850104105$domain:HECT, 850104774$domain:MIB/HERC2, 850105852$helix, 850106258$modified residue, 850116898$repeat:RCC1 1, 850116899$repeat:RCC1 10, 850116900$repeat:RCC1 11, 850116901$repeat:RCC1 12, 850116902$repeat:RCC1 13, 850116903$repeat:RCC1 14, 850116904$repeat:RCC1 15, 850116905$repeat:RCC1 16, 850116906$repeat:RCC1 17, 850116907$repeat:RCC1 18, 850116908$repeat:RCC1 19, 850116909$repeat:RCC1 2, 850116910$repeat:RCC1 3, 850116911$repeat:RCC1 4, 850116912$repeat:RCC1 5, 850116913$repeat:RCC1 6, 850116914$repeat:RCC1 7, 850116915$repeat:RCC1 8, 850116916$repeat:RCC1 9, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117294$sequence conflict, 850118575$strand, 850118624$turn, 850118951$zinc finger region:ZZ-type]
helicase (DNA) B,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
helicase (DNA) B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
helicase (DNA) B,UP_SEQ_FEATURE[850015566$chain:DNA helicase B, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hexokinase domain containing 1,COG_ONTOLOGY[90000016$Carbohydrate transport and metabolism]
hexokinase domain containing 1,INTERPRO[450001155$IPR001312:Hexokinase, 450018039$IPR019807:Hexokinase, conserved site]
hexokinase domain containing 1,PIR_SUPERFAMILY[630000626$PIRSF000527:hexokinase I]
hexokinase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000615$glycolysis, 790000825$kinase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001547$transferase]
hexokinase domain containing 1,UP_SEQ_FEATURE[850000242$binding site:ATP, 850051422$chain:Putative hexokinase HKDC1, 850106263$nucleotide phosphate-binding region:ATP, 850111773$region of interest:Glucose-binding, 850117295$sequence variant, 850118574$splice variant]
hippocalcin-like 1,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
hippocalcin-like 1,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
hippocalcin-like 1,PIR_SUPERFAMILY[630002469$PIRSF002350:calmodulin]
hippocalcin-like 1,SMART[760000046$SM00054:EFh]
hippocalcin-like 1,SP_PIR_KEYWORDS[790000189$blocked amino end, 790000211$calcium, 790000356$complete proteome, 790000480$EF hand, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001304$repeat]
hippocalcin-like 1,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850023765$chain:Hippocalcin-like protein 1, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850117294$sequence conflict]
histone cluster 2, H2bf,INTERPRO[450000478$IPR000558:Histone H2B, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
histone cluster 2, H2bf,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
histone cluster 2, H2bf,PIR_SUPERFAMILY[630002184$PIRSF002050:histone H2B]
histone cluster 2, H2bf,SMART[760000373$SM00427:H2B]
histone cluster 2, H2bf,SP_PIR_KEYWORDS[790000012$acetylation, 790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790000811$isopeptide bond, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation]
histone cluster 2, H2bf,UP_SEQ_FEATURE[850024035$chain:Histone H2B type 2-F, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue]
hypothetical protein LOC728621,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
hypothetical protein LOC728621,UP_SEQ_FEATURE[850012002$chain:Coiled-coil domain-containing protein 30, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
importin 7,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
importin 7,INTERPRO[450001329$IPR001494:Importin-beta, N-terminal, 450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450010814$IPR011989:Armadillo-like helical]
importin 7,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
importin 7,UP_SEQ_FEATURE[850025668$chain:Importin-7, 850102458$compositionally biased region:Asp-rich, 850104418$domain:Importin N-terminal, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant]
inositol hexakisphosphate kinase 2,INTERPRO[450004977$IPR005522:Inositol polyphosphate kinase]
inositol hexakisphosphate kinase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001547$transferase]
inositol hexakisphosphate kinase 2,UP_SEQ_FEATURE[850026033$chain:Inositol hexakisphosphate kinase 2, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850118574$splice variant]
inositol polyphosphate-4-phosphatase, type II, 105kDa,KEGG_PATHWAY[470038776$hsa00562:Inositol phosphate metabolism, 470038832$hsa04070:Phosphatidylinositol signaling system]
inositol polyphosphate-4-phosphatase, type II, 105kDa,PIR_SUPERFAMILY[630016131$PIRSF019532:inositol-3,4-bisphosphate 4-phosphatase type I/II]
inositol polyphosphate-4-phosphatase, type II, 105kDa,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism]
inositol polyphosphate-4-phosphatase, type II, 105kDa,UP_SEQ_FEATURE[850067392$chain:Type II inositol-3,4-bisphosphate 4- phosphatase, 850103199$domain:C2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
interferon-related developmental regulator 1,INTERPRO[450006320$IPR006921:Interferon-related developmental regulator, C-terminal, 450007056$IPR007701:Interferon-related developmental regulator, N-terminal]
interferon-related developmental regulator 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001162$phosphoprotein]
interferon-related developmental regulator 1,UP_SEQ_FEATURE[850026478$chain:Interferon-related developmental regulator 1, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850106258$modified residue, 850117294$sequence conflict]
interleukin 2 receptor, alpha,BBID[10000087$67.Ikaros_and_signaling_inhibitors]
interleukin 2 receptor, alpha,BIOCARTA[30000155$h_il2Pathway:IL 2 signaling pathway, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000294$h_th1th2Pathway:Th1/Th2 Differentiation, 30000299$h_tob1Pathway:Role of Tob in T-cell activation]
interleukin 2 receptor, alpha,INTERPRO[450000373$IPR000436:Sushi/SCR/CCP, 450013927$IPR015486:Interleukin-2 receptor alpha chain, 450014444$IPR016060:Complement control module]
interleukin 2 receptor, alpha,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038841$hsa04144:Endocytosis, 470038866$hsa04630:Jak-STAT signaling pathway, 470038867$hsa04640:Hematopoietic cell lineage]
interleukin 2 receptor, alpha,OMIM_DISEASE[520001490$Diabetes mellitus, insulin-dependent, susceptibility to, 520001491$Diabetes mellitus, insulin-dependent, susceptibility to, 10, 520001519$Diabetes, mellitus, insulin-dependent, susceptibility to, 10, 520001520$Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 520002662$Interleukin-2 receptor, alpha chain, deficiency of, 520003249$Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci, 520004352$Risk alleles for multiple sclerosis identified by a genomewide study]
interleukin 2 receptor, alpha,PIR_SUPERFAMILY[630002091$PIRSF001954:interleukin-2 receptor, alpha chain]
interleukin 2 receptor, alpha,SMART[760000024$SM00032:CCP]
interleukin 2 receptor, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000403$cytokine receptor, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000679$heterodimer, 790000687$heterotrimer, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001463$sulfoprotein, 790001471$sushi, 790001480$T-cell proliferation, 790001555$transmembrane, 790001556$transmembrane protein]
interleukin 2 receptor, alpha,UP_SEQ_FEATURE[850026553$chain:Interleukin-2 receptor subunit alpha, 850102883$disulfide bond, 850105416$domain:Sushi 1, 850105429$domain:Sushi 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
kallikrein-related peptidase 8,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
kallikrein-related peptidase 8,SMART[760000013$SM00020:Tryp_SPc]
kallikrein-related peptidase 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001652$zymogen]
kallikrein-related peptidase 8,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850027042$chain:Kallikrein-8, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
keratin 76,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 76,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 76,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790000821$keratin, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 76,UP_SEQ_FEATURE[850027205$chain:Keratin, type II cytoskeletal 2 oral, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant]
kininogen 1,BIOCARTA[30000165$h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway]
kininogen 1,INTERPRO[450000008$IPR000010:Proteinase inhibitor I25, cystatin, 450002128$IPR002395:HMW kininogen, 450016374$IPR018073:Proteinase inhibitor I25, cystatin, conserved site]
kininogen 1,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
kininogen 1,OMIM_DISEASE[520001913$Fitzgerald factor deficiency, 520002334$High molecular weight kininogen deficiency, 520002335$High-molecular-weight kininogen deficiency, 520002744$Kininogen deficiency]
kininogen 1,SMART[760000035$SM00043:CY]
kininogen 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000192$blood coagulation, 790000198$bradykinin, 790000356$complete proteome, 790000398$cysteine proteinase inhibitor, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000745$hydroxylation, 790000747$hydroxyproline, 790000775$inflammatory response, 790001162$phosphoprotein, 790001191$plasma, 790001212$polymorphism, 790001253$protease inhibitor, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat, 790001510$thiol protease inhibitor, 790001606$vasoactive, 790001608$vasodilator]
kininogen 1,UP_SEQ_FEATURE[850027560$chain:Kininogen-1, 850027561$chain:Kininogen-1 heavy chain, 850027562$chain:Kininogen-1 light chain, 850102540$compositionally biased region:His-rich, 850102883$disulfide bond, 850103469$domain:Cystatin 1, 850103470$domain:Cystatin 2, 850103471$domain:Cystatin 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850106258$modified residue, 850106774$peptide:Bradykinin, 850108110$peptide:Low molecular weight growth-promoting factor, 850108134$peptide:Lysyl-bradykinin, 850109303$peptide:T-kinin, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118073$site:Cleavage; by kallikrein, 850118450$site:Not glycosylated, 850118574$splice variant]
late cornified envelope 2A,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 2A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 2A,UP_SEQ_FEATURE[850028026$chain:Late cornified envelope protein 2A, 850102480$compositionally biased region:Cys-rich, 850117295$sequence variant]
lectin, galactoside-binding, soluble, 14,INTERPRO[450000945$IPR001079:Galectin, carbohydrate recognition domain, 450011956$IPR013320:Concanavalin A-like lectin/glucanase, subgroup]
lectin, galactoside-binding, soluble, 14,SMART[760000247$SM00276:GLECT]
lectin, galactoside-binding, soluble, 14,SP_PIR_KEYWORDS[790000356$complete proteome, 790000848$Lectin, 790001065$nucleus, 790001212$polymorphism]
lectin, galactoside-binding, soluble, 14,UP_SEQ_FEATURE[850039417$chain:Placental protein 13-like, 850104037$domain:Galectin, 850117294$sequence conflict, 850117295$sequence variant]
low density lipoprotein receptor-related protein 5,INTERPRO[450000026$IPR000033:Low-density lipoprotein receptor, YWTD repeat, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011699$IPR013032:EGF-like region, conserved site, 450015369$IPR017049:Low density lipoprotein receptor-related protein, 5/6, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
low density lipoprotein receptor-related protein 5,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
low density lipoprotein receptor-related protein 5,OMIM_DISEASE[520000647$Bone mineral density variability 1, 520000650$Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study, 520001836$Exudative vitreoretinopathy 4, 520002450$Hyperostosis, endosteal, 520003818$Osteopetrosis, AD type I, 520003831$Osteoporosis, 520003837$Osteoporosis-pseudoglioma syndrome, 520003840$Osteosclerosis, 520005010$van Buchem disease, type 2]
low density lipoprotein receptor-related protein 5,PIR_SUPERFAMILY[630027750$PIRSF036314:LDL_recpt-rel_p5/6, 630027751$PIRSF036314:low density lipoprotein receptor-related protein, 5/6 types, 630030929$PIRSF500770:low-density lipoprotein receptor-related protein 5]
low density lipoprotein receptor-related protein 5,SMART[760000117$SM00135:LY, 760000155$SM00181:EGF, 760000166$SM00192:LDLa]
low density lipoprotein receptor-related protein 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000496$Endocytosis, 790000616$glycoprotein, 790000881$lipoprotein, 790000919$membrane, 790001084$osteopetrosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001642$wnt signaling pathway]
low density lipoprotein receptor-related protein 5,UP_SEQ_FEATURE[850029132$chain:Low-density lipoprotein receptor-related protein 5, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850104665$domain:LDL-receptor class A 1, 850104678$domain:LDL-receptor class A 2, 850104691$domain:LDL-receptor class A 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850116264$repeat:LDL-receptor class B 1, 850116265$repeat:LDL-receptor class B 10, 850116266$repeat:LDL-receptor class B 11, 850116267$repeat:LDL-receptor class B 12, 850116268$repeat:LDL-receptor class B 13, 850116269$repeat:LDL-receptor class B 14, 850116270$repeat:LDL-receptor class B 15, 850116271$repeat:LDL-receptor class B 16, 850116272$repeat:LDL-receptor class B 17, 850116273$repeat:LDL-receptor class B 18, 850116274$repeat:LDL-receptor class B 19, 850116275$repeat:LDL-receptor class B 2, 850116276$repeat:LDL-receptor class B 20, 850116286$repeat:LDL-receptor class B 3, 850116295$repeat:LDL-receptor class B 4, 850116296$repeat:LDL-receptor class B 5, 850116297$repeat:LDL-receptor class B 6, 850116298$repeat:LDL-receptor class B 7, 850116299$repeat:LDL-receptor class B 8, 850116300$repeat:LDL-receptor class B 9, 850117267$repeat:YWTD 1, 850117268$repeat:YWTD 10, 850117269$repeat:YWTD 11, 850117270$repeat:YWTD 2, 850117271$repeat:YWTD 3, 850117272$repeat:YWTD 4, 850117273$repeat:YWTD 5, 850117274$repeat:YWTD 6, 850117275$repeat:YWTD 7, 850117276$repeat:YWTD 8, 850117277$repeat:YWTD 9, 850117294$sequence conflict, 850117295$sequence variant, 850117651$short sequence motif:PPPSP motif, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
lumican,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
lumican,PIR_SUPERFAMILY[630005362$PIRSF005438:class II small leucine-rich proteoglycan, 630030687$PIRSF500473:lumican]
lumican,SMART[760000007$SM00013:LRRNT, 760000333$SM00369:LRR_TYP]
lumican,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001269$proteoglycan, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001461$sulfation]
lumican,UP_SEQ_FEATURE[850029183$chain:Lumican, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105784$glycosylation site:N-linked (GlcNAc...) (keratan sulfate), 850106258$modified residue, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117814$signal peptide]
matrix metallopeptidase 1 (interstitial collagenase),INTERPRO[450000498$IPR000585:Hemopexin/matrixin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002196$IPR002477:Peptidoglycan binding-like, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450005466$IPR006026:Peptidase, metallopeptidases, 450014617$IPR016293:Peptidase M10A, matrix metallopeotidase, 450016760$IPR018486:Hemopexin/matrixin, conserved site, 450016761$IPR018487:Hemopexin/matrixin, repeat]
matrix metallopeptidase 1 (interstitial collagenase),KEGG_PATHWAY[470038821$hsa03320:PPAR signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038909$hsa05219:Bladder cancer]
matrix metallopeptidase 1 (interstitial collagenase),OMIM_DISEASE[520001203$COPD, rate of decline of lung function in, 520001708$Epidermolysis bullosa dystrophica, autosomal recessive, modifier of]
matrix metallopeptidase 1 (interstitial collagenase),PIR_SUPERFAMILY[630001331$PIRSF001191:matrix metalloproteinase, stromelysin type, 630001332$PIRSF001191:Peptidase_M10A_matrix]
matrix metallopeptidase 1 (interstitial collagenase),SMART[760000105$SM00120:HX, 760000207$SM00235:ZnMc]
matrix metallopeptidase 1 (interstitial collagenase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000144$autocatalytic cleavage, 790000211$calcium, 790000345$collagen, 790000347$collagen degradation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000550$fibroblast, 790000616$glycoprotein, 790000733$host-virus interaction, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000944$metalloproteinase, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc, 790001652$zymogen]
matrix metallopeptidase 1 (interstitial collagenase),UP_SEQ_FEATURE[850001196$chain:22 kDa interstitial collagenase, 850001292$chain:27 kDa interstitial collagenase, 850026638$chain:Interstitial collagenase, 850102883$disulfide bond, 850104116$domain:Hemopexin-like 1, 850104117$domain:Hemopexin-like 2, 850104118$domain:Hemopexin-like 3, 850104119$domain:Hemopexin-like 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105910$metal ion-binding site:Calcium 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850105925$metal ion-binding site:Calcium 3, 850105927$metal ion-binding site:Calcium 3; via carbonyl oxygen, 850105930$metal ion-binding site:Calcium 4; via carbonyl oxygen, 850106219$metal ion-binding site:Zinc 1, 850106227$metal ion-binding site:Zinc 2; catalytic, 850106228$metal ion-binding site:Zinc 2; in inhibited form, 850109636$propeptide:Activation peptide, 850113432$region of interest:Metalloprotease, 850117294$sequence conflict, 850117295$sequence variant, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118006$site:Cleavage; by autolysis, 850118575$strand, 850118624$turn]
matrix metallopeptidase 13 (collagenase 3),INTERPRO[450000498$IPR000585:Hemopexin/matrixin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002196$IPR002477:Peptidoglycan binding-like, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450005466$IPR006026:Peptidase, metallopeptidases, 450014617$IPR016293:Peptidase M10A, matrix metallopeotidase, 450016760$IPR018486:Hemopexin/matrixin, conserved site, 450016761$IPR018487:Hemopexin/matrixin, repeat]
matrix metallopeptidase 13 (collagenase 3),OMIM_DISEASE[520004657$Spondyloepimetaphyseal dysplasia, Missouri type]
matrix metallopeptidase 13 (collagenase 3),PIR_SUPERFAMILY[630001331$PIRSF001191:matrix metalloproteinase, stromelysin type, 630001332$PIRSF001191:Peptidase_M10A_matrix]
matrix metallopeptidase 13 (collagenase 3),SMART[760000105$SM00120:HX, 760000207$SM00235:ZnMc]
matrix metallopeptidase 13 (collagenase 3),SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000345$collagen, 790000347$collagen degradation, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000944$metalloproteinase, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc, 790001652$zymogen]
matrix metallopeptidase 13 (collagenase 3),UP_SEQ_FEATURE[850012235$chain:Collagenase 3, 850102883$disulfide bond, 850104116$domain:Hemopexin-like 1, 850104117$domain:Hemopexin-like 2, 850104118$domain:Hemopexin-like 3, 850104119$domain:Hemopexin-like 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105910$metal ion-binding site:Calcium 1, 850105915$metal ion-binding site:Calcium 1; via carbonyl oxygen, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850105927$metal ion-binding site:Calcium 3; via carbonyl oxygen, 850105930$metal ion-binding site:Calcium 4; via carbonyl oxygen, 850106219$metal ion-binding site:Zinc 1, 850106227$metal ion-binding site:Zinc 2; catalytic, 850106228$metal ion-binding site:Zinc 2; in inhibited form, 850109636$propeptide:Activation peptide, 850117295$sequence variant, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118575$strand, 850118624$turn]
microspherule protein 1,INTERPRO[450000219$IPR000253:Forkhead-associated]
microspherule protein 1,SMART[760000212$SM00240:FHA]
microspherule protein 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
microspherule protein 1,UP_SEQ_FEATURE[850031678$chain:Microspherule protein 1, 850102597$compositionally biased region:Ser-rich, 850103775$domain:FHA, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
microtubule-associated protein 6,INTERPRO[450007230$IPR007882:STOP]
microtubule-associated protein 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000218$calmodulin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000624$golgi apparatus, 790000881$lipoprotein, 790000960$microtubule, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism]
microtubule-associated protein 6,UP_SEQ_FEATURE[850031691$chain:Microtubule-associated protein 6, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850111164$region of interest:Calmodulin-binding, 850113457$region of interest:Mn 1, 850113458$region of interest:Mn 2, 850113459$region of interest:Mn 3, 850117295$sequence variant, 850118574$splice variant]
mitochondrial carrier homolog 2 (C. elegans),INTERPRO[450016408$IPR018108:Mitochondrial substrate/solute carrier]
mitochondrial carrier homolog 2 (C. elegans),OMIM_DISEASE[520004491$Six new loci associated with body mass index highlight a neuronal influence on body weight regulation]
mitochondrial carrier homolog 2 (C. elegans),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
mitochondrial carrier homolog 2 (C. elegans),UP_SEQ_FEATURE[850031844$chain:Mitochondrial carrier homolog 2, 850106258$modified residue, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117295$sequence variant, 850118623$transmembrane region]
mitofusin 2,INTERPRO[450001246$IPR001401:Dynamin, GTPase region, 450006284$IPR006884:Fzo-like conserved region]
mitofusin 2,OMIM_DISEASE[520000951$Charcot-Marie-Tooth disease, type 2A2, 520002297$Hereditary motor and sensory neuropathy VI]
mitofusin 2,SMART[760000045$SM00053:DYNc]
mitofusin 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000289$charcot-marie-tooth disease, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000639$gtp-binding, 790000743$hydrolase, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001020$neuropathy, 790001063$nucleotide-binding, 790001555$transmembrane]
mitofusin 2,UP_SEQ_FEATURE[850032062$chain:Mitofusin-2, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118594$topological domain:Mitochondrial intermembrane, 850118623$transmembrane region]
mitogen-activated protein kinase 8 interacting protein 1,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
mitogen-activated protein kinase 8 interacting protein 1,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
mitogen-activated protein kinase 8 interacting protein 1,OMIM_DISEASE[520001498$Diabetes mellitus, noninsulin-dependent]
mitogen-activated protein kinase 8 interacting protein 1,SMART[760000295$SM00326:SH3, 760000407$SM00462:PTB]
mitogen-activated protein kinase 8 interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000430$diabetes mellitus, 790000446$disease mutation, 790000825$kinase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain, 790001592$ubl conjugation]
mitogen-activated protein kinase 8 interacting protein 1,UP_SEQ_FEATURE[850008633$chain:C-jun-amino-terminal kinase-interacting protein 1, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850104993$domain:PID, 850105350$domain:SH3, 850106258$modified residue, 850106259$mutagenesis site, 850113235$region of interest:JNK-binding domain (JBD), 850113452$region of interest:Minimal inhibitory domain (MID), 850117295$sequence variant, 850117371$short sequence motif:D-box 1, 850117372$short sequence motif:D-box 2]
mutL homolog 3 (E. coli),COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
mutL homolog 3 (E. coli),INTERPRO[450001859$IPR002099:DNA mismatch repair protein, 450003155$IPR003594:ATP-binding region, ATPase-like, 450012134$IPR013507:DNA mismatch repair protein, C-terminal, 450013173$IPR014721:Ribosomal protein S5 domain 2-type fold, 450013212$IPR014762:DNA mismatch repair, conserved site, 450013240$IPR014790:MutL, C-terminal, dimerisation]
mutL homolog 3 (E. coli),KEGG_PATHWAY[470038824$hsa03430:Mismatch repair]
mutL homolog 3 (E. coli),OMIM_DISEASE[520001083$Colon cancer, hereditary nonpolypopsis, type 7, 520001101$Colorectal cancer, somatic]
mutL homolog 3 (E. coli),SMART[760000339$SM00387:HATPase_c]
mutL homolog 3 (E. coli),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000674$hereditary nonpolyposis colorectal cancer, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
mutL homolog 3 (E. coli),UP_SEQ_FEATURE[850015587$chain:DNA mismatch repair protein MLH3, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3,INTERPRO[450004502$IPR005033:YEATS]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3,PIR_SUPERFAMILY[630028760$PIRSF037229:MLLT]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3,SP_PIR_KEYWORDS[790000020$activator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001539$Transcription, 790001543$transcription regulation]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3,UP_SEQ_FEATURE[850045003$chain:Protein AF-9, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850105744$domain:YEATS, 850106258$modified residue, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118436$site:MLL fusion point (in acute myeloid leukemia patient CO), 850118437$site:MLL fusion point (in acute myeloid leukemia patient F1)]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,INTERPRO[450009680$IPR010630:Neuroblastoma breakpoint family]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,UP_SEQ_FEATURE[850033937$chain:Neuroblastoma breakpoint family member 1, 850033938$chain:Neuroblastoma breakpoint family member 10, 850033939$chain:Neuroblastoma breakpoint family member 11, 850033940$chain:Neuroblastoma breakpoint family member 12, 850033941$chain:Neuroblastoma breakpoint family member 14, 850033942$chain:Neuroblastoma breakpoint family member 15, 850033944$chain:Neuroblastoma breakpoint family member 20, 850033950$chain:Neuroblastoma breakpoint family member 8, 850033951$chain:Neuroblastoma breakpoint family member 9, 850102566$compositionally biased region:Poly-Arg, 850102572$compositionally biased region:Poly-Glu, 850104832$domain:NBPF 1, 850104833$domain:NBPF 10, 850104834$domain:NBPF 2, 850104835$domain:NBPF 3, 850104836$domain:NBPF 4, 850104837$domain:NBPF 5, 850104838$domain:NBPF 6, 850104839$domain:NBPF 7, 850104840$domain:NBPF 8, 850104841$domain:NBPF 9, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
non imprinted in Prader-Willi/Angelman syndrome 1,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450007794$IPR008521:Protein of unknown function DUF803]
non imprinted in Prader-Willi/Angelman syndrome 1,OMIM_DISEASE[520004569$Spastic paraplegia-6]
non imprinted in Prader-Willi/Angelman syndrome 1,SMART[760000401$SM00456:WW]
non imprinted in Prader-Willi/Angelman syndrome 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000501$endosome, 790000675$hereditary spastic paraplegia, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790001015$neurodegeneration, 790001555$transmembrane, 790001558$transport]
non imprinted in Prader-Willi/Angelman syndrome 1,UP_SEQ_FEATURE[850030007$chain:Magnesium transporter NIPA1, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
nuclear mitotic apparatus protein 1,BIOCARTA[30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000251$h_ranMSpathway:Role of Ran in mitotic spindle regulation]
nuclear mitotic apparatus protein 1,OMIM_DISEASE[520002848$Leukemia, acute promyelocytic, NUMA/RARA type]
nuclear mitotic apparatus protein 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
nuclear mitotic apparatus protein 1,UP_SEQ_FEATURE[850034986$chain:Nuclear mitotic apparatus protein 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
nuclear receptor coactivator 7,INTERPRO[450002201$IPR002482:Peptidoglycan-binding Lysin subgroup, 450003692$IPR004182:GRAM, 450005991$IPR006571:TLDc, 450016672$IPR018392:Peptidoglycan-binding lysin domain]
nuclear receptor coactivator 7,SMART[760000229$SM00257:LysM, 760000505$SM00568:GRAM, 760000520$SM00584:TLDc]
nuclear receptor coactivator 7,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation]
nuclear receptor coactivator 7,UP_SEQ_FEATURE[850035035$chain:Nuclear receptor coactivator 7, 850105532$domain:TLD, 850106258$modified residue, 850106259$mutagenesis site, 850116349$repeat:LysM, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
nuclear receptor interacting protein 3,INTERPRO[450017359$IPR019103:Peptidase aspartic, eukaryotic predicted]
nuclear receptor interacting protein 3,SP_PIR_KEYWORDS[790000356$complete proteome]
nuclear receptor interacting protein 3,UP_SEQ_FEATURE[850035069$chain:Nuclear receptor-interacting protein 3]
nuclear receptor subfamily 1, group H, member 3,BIOCARTA[30000118$h_fxrPathway:FXR and LXR Regulation of Cholesterol Metabolism, 30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity, 30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)]
nuclear receptor subfamily 1, group H, member 3,INTERPRO[450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450000806$IPR000923:Blue (type 1) copper domain, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450001531$IPR001728:Thyroid hormone receptor, 450006475$IPR007087:Zinc finger, C2H2-type, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
nuclear receptor subfamily 1, group H, member 3,KEGG_PATHWAY[470038821$hsa03320:PPAR signaling pathway]
nuclear receptor subfamily 1, group H, member 3,OMIM_DISEASE[520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population]
nuclear receptor subfamily 1, group H, member 3,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
nuclear receptor subfamily 1, group H, member 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
nuclear receptor subfamily 1, group H, member 3,UP_SEQ_FEATURE[850036544$chain:Oxysterols receptor LXR-alpha, 850102946$DNA-binding region:Nuclear receptor, 850105852$helix, 850113269$region of interest:Ligand-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118866$zinc finger region:NR C4-type]
nucleoporin 98kDa,INTERPRO[450006599$IPR007230:Peptidase S59, nucleoporin]
nucleoporin 98kDa,OMIM_DISEASE[520002859$Leukemia, lymphycytic, acute T-cell]
nucleoporin 98kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001554$translocation, 790001558$transport]
nucleoporin 98kDa,UP_SEQ_FEATURE[850035011$chain:Nuclear pore complex protein Nup96, 850035012$chain:Nuclear pore complex protein Nup98, 850102537$compositionally biased region:Gly/Thr-rich, 850102572$compositionally biased region:Poly-Glu, 850104971$domain:Peptidase S59, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117920$site:Breakpoint for translocation to form NUP98-PHF23 oncogene, 850118574$splice variant, 850118575$strand, 850118624$turn]
nucleosome assembly protein 1-like 4,INTERPRO[450001919$IPR002164:Nucleosome assembly protein (NAP)]
nucleosome assembly protein 1-like 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein]
nucleosome assembly protein 1-like 4,UP_SEQ_FEATURE[850035326$chain:Nucleosome assembly protein 1-like 4, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117610$short sequence motif:Nuclear localization signal]
nurim (nuclear envelope membrane protein),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001555$transmembrane]
nurim (nuclear envelope membrane protein),UP_SEQ_FEATURE[850035377$chain:Nurim, 850102552$compositionally biased region:Leu-rich, 850102576$compositionally biased region:Poly-Leu, 850118574$splice variant, 850118623$transmembrane region]
olfactory receptor, family 10, subfamily K, member 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 10, subfamily K, member 1,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 10, subfamily K, member 1,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 10, subfamily K, member 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 10, subfamily K, member 1,UP_SEQ_FEATURE[850035544$chain:Olfactory receptor 10K1, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
pappalysin 2,INTERPRO[450000373$IPR000436:Sushi/SCR/CCP, 450000694$IPR000800:Notch region, 450003484$IPR003961:Fibronectin, type III, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450008006$IPR008754:Peptidase M43B, pregnancy-associated plasma-A, 450010761$IPR011936:Myxococcus cysteine-rich repeat, 450014444$IPR016060:Complement control module]
pappalysin 2,SMART[760000003$SM00004:NL, 760000024$SM00032:CCP, 760000051$SM00060:FN3]
pappalysin 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001471$sushi, 790001648$zinc, 790001652$zymogen]
pappalysin 2,UP_SEQ_FEATURE[850036812$chain:Pappalysin-2, 850102580$compositionally biased region:Poly-Pro, 850102582$compositionally biased region:Poly-Thr, 850102883$disulfide bond, 850105416$domain:Sushi 1, 850105429$domain:Sushi 2, 850105440$domain:Sushi 3, 850105446$domain:Sushi 4, 850105447$domain:Sushi 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850106244$metal ion-binding site:Zinc; catalytic, 850106259$mutagenesis site, 850113432$region of interest:Metalloprotease, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
peroxiredoxin 2,INTERPRO[450000755$IPR000866:Alkyl hydroperoxide reductase/ Thiol specific antioxidant/ Mal allergen, 450011036$IPR012335:Thioredoxin fold, 450016249$IPR017936:Thioredoxin-like, 450017717$IPR019479:Peroxiredoxin, C-terminal]
peroxiredoxin 2,PIR_SUPERFAMILY[630000283$PIRSF000239:alkyl hydroperoxide reductase C22 protein]
peroxiredoxin 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000101$antioxidant, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000652$heme, 790001092$oxidoreductase, 790001127$peroxidase, 790001212$polymorphism, 790001302$Redox-active center]
peroxiredoxin 2,UP_SEQ_FEATURE[850000021$active site:Cysteine sulfenic acid (-SOH) intermediate, 850037897$chain:Peroxiredoxin-2, 850102883$disulfide bond, 850105478$domain:Thioredoxin, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
peroxisomal biogenesis factor 16,INTERPRO[450012514$IPR013919:Peroxisome membrane protein, Pex16]
peroxisomal biogenesis factor 16,OMIM_DISEASE[520005136$Zellweger syndrome, complementation group 9]
peroxisomal biogenesis factor 16,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001128$peroxisome, 790001129$peroxisome biogenesis, 790001130$peroxisome biogenesis disorder, 790001212$polymorphism, 790001555$transmembrane, 790001647$zellweger syndrome]
peroxisomal biogenesis factor 16,UP_SEQ_FEATURE[850037961$chain:Peroxisomal membrane protein PEX16, 850112668$region of interest:Interaction with PEX19, 850114450$region of interest:Required for peroxisomal location, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118601$topological domain:Peroxisomal, 850118623$transmembrane region]
peroxisome proliferator-activated receptor gamma, coactivator-related 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
peroxisome proliferator-activated receptor gamma, coactivator-related 1,SMART[760000328$SM00360:RRM]
peroxisome proliferator-activated receptor gamma, coactivator-related 1,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation]
peroxisome proliferator-activated receptor gamma, coactivator-related 1,UP_SEQ_FEATURE[850038006$chain:Peroxisome proliferator-activated receptor gamma coactivator-related protein 1, 850102404$compositionally biased region:Arg-rich, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850105211$domain:RRM, 850113602$region of interest:Necessary for interaction with CREB1 and NRF1, 850113603$region of interest:Necessary for interaction with CREB1 and NRF1 and for transcriptional coactivation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
phosphatidylinositol transfer protein, membrane-associated 1,INTERPRO[450001476$IPR001666:Phosphatidylinositol transfer protein, 450003687$IPR004177:DDHD, 450011846$IPR013209:LNS2, Lipin/Ned1/Smp2]
phosphatidylinositol transfer protein, membrane-associated 1,SMART[760000680$SM00775:LNS2]
phosphatidylinositol transfer protein, membrane-associated 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000871$lipid droplet, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
phosphatidylinositol transfer protein, membrane-associated 1,UP_SEQ_FEATURE[850031134$chain:Membrane-associated phosphatidylinositol transfer protein 1, 850102581$compositionally biased region:Poly-Ser, 850103504$domain:DDHD, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
phosphatidylinositol transfer protein, membrane-associated 2,INTERPRO[450001476$IPR001666:Phosphatidylinositol transfer protein, 450003687$IPR004177:DDHD, 450011846$IPR013209:LNS2, Lipin/Ned1/Smp2]
phosphatidylinositol transfer protein, membrane-associated 2,SMART[760000680$SM00775:LNS2]
phosphatidylinositol transfer protein, membrane-associated 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000876$lipid-binding, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism]
phosphatidylinositol transfer protein, membrane-associated 2,UP_SEQ_FEATURE[850031135$chain:Membrane-associated phosphatidylinositol transfer protein 2, 850102517$compositionally biased region:Gly-rich, 850103504$domain:DDHD, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
platelet endothelial aggregation receptor 1,INTERPRO[450000637$IPR000742:EGF-like, type 3, 450001815$IPR002049:EGF-like, laminin, 450005636$IPR006210:EGF-like, 450010351$IPR011489:EMI domain, 450011699$IPR013032:EGF-like region, conserved site, 450011755$IPR013111:EGF, extracellular]
platelet endothelial aggregation receptor 1,SMART[760000154$SM00180:EGF_Lam, 760000155$SM00181:EGF]
platelet endothelial aggregation receptor 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
platelet endothelial aggregation receptor 1,UP_SEQ_FEATURE[850039511$chain:Platelet endothelial aggregation receptor 1, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103698$domain:EGF-like 7, 850103700$domain:EGF-like 8, 850103702$domain:EGF-like 9, 850103714$domain:EMI, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118623$transmembrane region]
poly (ADP-ribose) polymerase family, member 11,INTERPRO[450003680$IPR004170:WWE domain, 450011020$IPR012317:Poly(ADP-ribose) polymerase, catalytic region]
poly (ADP-ribose) polymerase family, member 11,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000619$glycosyltransferase, 790001006$nad, 790001547$transferase]
poly (ADP-ribose) polymerase family, member 11,UP_SEQ_FEATURE[850039710$chain:Poly [ADP-ribose] polymerase 11, 850104895$domain:PARP catalytic, 850105736$domain:WWE, 850105852$helix, 850118574$splice variant, 850118575$strand, 850118624$turn]
polycomb group ring finger 5,COG_ONTOLOGY[90000073$General function prediction only]
polycomb group ring finger 5,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
polycomb group ring finger 5,SMART[760000158$SM00184:RING]
polycomb group ring finger 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
polycomb group ring finger 5,UP_SEQ_FEATURE[850039824$chain:Polycomb group RING finger protein 5, 850118574$splice variant, 850118911$zinc finger region:RING-type]
polymerase (RNA) II (DNA directed) polypeptide F,INTERPRO[450005543$IPR006110:RNA polymerase Rpb6, 450005544$IPR006111:DNA-directed RNA polymerase, 14 to 18 kDa subunit, 450011003$IPR012293:RNA polymerase subunit, RPB6/omega]
polymerase (RNA) II (DNA directed) polypeptide F,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism, 470038815$hsa03020:RNA polymerase, 470038894$hsa05016:Huntington's disease]
polymerase (RNA) II (DNA directed) polypeptide F,PIR_SUPERFAMILY[630000900$PIRSF000778:DNA-directed RNA polymerase, subunit K/RPB6 subunit, 630030417$PIRSF500154:DNA-directed RNA polymerase, RPB6 type]
polymerase (RNA) II (DNA directed) polypeptide F,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000468$dna-directed rna polymerase, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription]
polymerase (RNA) II (DNA directed) polypeptide F,UP_SEQ_FEATURE[850016115$chain:DNA-directed RNA polymerases I, II, and III subunit RPABC2, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
post-GPI attachment to proteins 2,INTERPRO[450017640$IPR019402:Frag1/DRAM/Sfk1]
post-GPI attachment to proteins 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000629$gpi-anchor biosynthesis, 790000919$membrane, 790001555$transmembrane]
post-GPI attachment to proteins 2,UP_SEQ_FEATURE[850040025$chain:Post-GPI attachment to proteins factor 2, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,INTERPRO[450001818$IPR002052:N-6 adenine-specific DNA methylase, conserved site, 450002716$IPR003091:Voltage-dependent potassium channel, 450003454$IPR003929:Potassium channel, calcium-activated, BK, alpha subunit, 450005268$IPR005821:Ion transport, 450011743$IPR013099:Ion transport 2, 450014426$IPR016040:NAD(P)-binding domain]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,KEGG_PATHWAY[470038845$hsa04270:Vascular smooth muscle contraction]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,OMIM_DISEASE[520001979$Generalized epilepsy and paroxysmal dyskinesia]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,PIR_SUPERFAMILY[630012418$PIRSF015660:calcium-activated potassium channel, alpha subunit]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000446$disease mutation, 790000509$epilepsy, 790000798$ion transport, 790000799$ionic channel, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,UP_SEQ_FEATURE[850008948$chain:Calcium-activated potassium channel subunit alpha-1, 850102573$compositionally biased region:Poly-Gly, 850102581$compositionally biased region:Poly-Ser, 850105157$domain:RCK N-terminal, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106259$mutagenesis site, 850111848$region of interest:Heme-binding motif, 850114086$region of interest:Pore-forming, in membrane, 850114615$region of interest:Segment S10, 850114617$region of interest:Segment S7, 850114618$region of interest:Segment S8, 850114619$region of interest:Segment S9, 850117294$sequence conflict, 850117295$sequence variant, 850117332$short sequence motif:Calcium bowl, 850117704$short sequence motif:Selectivity for potassium, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,INTERPRO[450003455$IPR003930:Potassium channel, calcium-activated, BK, beta subunit]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,KEGG_PATHWAY[470038845$hsa04270:Vascular smooth muscle contraction]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,PIR_SUPERFAMILY[630014757$PIRSF018113:calcium-activated potassium channel, beta subunit, 630031023$PIRSF500875:calcium-activated potassium channel, beta 4 subunit]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,UP_SEQ_FEATURE[850008952$chain:Calcium-activated potassium channel subunit beta-4, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
profilin family, member 4,INTERPRO[450001857$IPR002097:Profilin/allergen, 450004914$IPR005455:Profilin, plant]
profilin family, member 4,KEGG_PATHWAY[470038881$hsa04810:Regulation of actin cytoskeleton]
profilin family, member 4,PIR_SUPERFAMILY[630002462$PIRSF002342:profilin]
profilin family, member 4,SMART[760000344$SM00392:PROF]
profilin family, member 4,SP_PIR_KEYWORDS[790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton]
profilin family, member 4,UP_SEQ_FEATURE[850044477$chain:Profilin-4]
progestin and adipoQ receptor family member V,BIOCARTA[30000191$h_mPRPathway:How Progesterone Initiates the Oocyte Maturation]
progestin and adipoQ receptor family member V,INTERPRO[450003761$IPR004254:Hly-III related]
progestin and adipoQ receptor family member V,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000876$lipid-binding, 790000919$membrane, 790001077$oogenesis, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001443$steroid-binding, 790001555$transmembrane]
progestin and adipoQ receptor family member V,UP_SEQ_FEATURE[850031090$chain:Membrane progestin receptor gamma, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
proline-serine-threonine phosphatase interacting protein 1,INTERPRO[450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001294$IPR001452:Src homology-3 domain, 450011951$IPR013315:Spectrin alpha chain, SH3 domain]
proline-serine-threonine phosphatase interacting protein 1,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
proline-serine-threonine phosphatase interacting protein 1,OMIM_DISEASE[520004198$Pyogenic sterile arthritis, pyoderma gangrenosum, and acne]
proline-serine-threonine phosphatase interacting protein 1,SMART[760000047$SM00055:FCH, 760000295$SM00326:SH3]
proline-serine-threonine phosphatase interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000446$disease mutation, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
proline-serine-threonine phosphatase interacting protein 1,UP_SEQ_FEATURE[850044631$chain:Proline-serine-threonine phosphatase- interacting protein 1, 850103755$domain:FCH, 850105350$domain:SH3, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
prostaglandin E synthase 2,INTERPRO[450001869$IPR002109:Glutaredoxin, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450010594$IPR011767:Glutaredoxin active site, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
prostaglandin E synthase 2,KEGG_PATHWAY[470038780$hsa00590:Arachidonic acid metabolism]
prostaglandin E synthase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000542$Fatty acid biosynthesis, 790000624$golgi apparatus, 790000810$Isomerase, 790000874$lipid synthesis, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001249$prostaglandin biosynthesis, 790001555$transmembrane]
prostaglandin E synthase 2,UP_SEQ_FEATURE[850044708$chain:Prostaglandin E synthase 2, 850044709$chain:Prostaglandin E synthase 2 truncated form, 850104060$domain:Glutaredoxin, 850104084$domain:GST C-terminal, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117969$site:Cleavage, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
proteasome (prosome, macropain) subunit, alpha type, 5,INTERPRO[450000365$IPR000426:Proteasome, alpha-subunit, conserved site, 450001196$IPR001353:Proteasome, alpha and beta subunits, 450001197$IPR001353:Proteasome, subunit alpha/beta]
proteasome (prosome, macropain) subunit, alpha type, 5,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) subunit, alpha type, 5,PIR_SUPERFAMILY[630001352$PIRSF001212:multicatalytic endopeptidase complex chain C9]
proteasome (prosome, macropain) subunit, alpha type, 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001252$Protease, 790001254$proteasome, 790001267$proteinase, 790001516$threonine protease]
proteasome (prosome, macropain) subunit, alpha type, 5,UP_SEQ_FEATURE[850044865$chain:Proteasome subunit alpha type-5, 850106258$modified residue, 850117294$sequence conflict]
protein kinase C and casein kinase substrate in neurons 3,INTERPRO[450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001294$IPR001452:Src homology-3 domain]
protein kinase C and casein kinase substrate in neurons 3,SMART[760000047$SM00055:FCH, 760000295$SM00326:SH3]
protein kinase C and casein kinase substrate in neurons 3,SP_PIR_KEYWORDS[790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000496$Endocytosis, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
protein kinase C and casein kinase substrate in neurons 3,UP_SEQ_FEATURE[850046574$chain:Protein kinase C and casein kinase substrate in neurons protein 3, 850103755$domain:FCH, 850105350$domain:SH3, 850106258$modified residue, 850117295$sequence variant]
protein phosphatase 4, regulatory subunit 4,INTERPRO[450000307$IPR000357:HEAT, 450010814$IPR011989:Armadillo-like helical]
protein phosphatase 4, regulatory subunit 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001304$repeat]
protein phosphatase 4, regulatory subunit 4,UP_SEQ_FEATURE[850060137$chain:Serine/threonine-protein phosphatase 4 regulatory subunit 4, 850106259$mutagenesis site, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850118574$splice variant]
protein tyrosine phosphatase, mitochondrial 1,INTERPRO[450000291$IPR000340:Dual specificity phosphatase, catalytic domain, 450000292$IPR000340:Protein-tyrosine phosphatase, dual specificity, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, mitochondrial 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001261$protein phosphatase, 790001550$transit peptide]
protein tyrosine phosphatase, mitochondrial 1,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850048625$chain:Protein-tyrosine phosphatase mitochondrial 1, 850105593$domain:Tyrosine-protein phosphatase, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
protein tyrosine phosphatase, non-receptor type 23,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
protein tyrosine phosphatase, non-receptor type 23,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450003837$IPR004328:BRO1, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, non-receptor type 23,SMART[760000168$SM00194:PTPc]
protein tyrosine phosphatase, non-receptor type 23,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism, 790001261$protein phosphatase, 790001304$repeat, 790001537$tpr repeat]
protein tyrosine phosphatase, non-receptor type 23,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067656$chain:Tyrosine-protein phosphatase non-receptor type 23, 850102586$compositionally biased region:Pro-rich, 850103165$domain:BRO1, 850105593$domain:Tyrosine-protein phosphatase, 850106258$modified residue, 850110569$region of interest:6 X 2 AA approximate tandem repeats of P- Q, 850111885$region of interest:His, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117294$sequence conflict, 850117295$sequence variant]
protein tyrosine phosphatase, receptor type, F,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450003159$IPR003598:Immunoglobulin subtype 2, 450003484$IPR003961:Fibronectin, type III, 450003485$IPR003962:Fibronectin, type III subdomain, 450006486$IPR007110:Immunoglobulin-like, 450008173$IPR008957:Fibronectin, type III-like fold, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, receptor type, F,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038856$hsa04520:Adherens junction, 470038882$hsa04910:Insulin signaling pathway]
protein tyrosine phosphatase, receptor type, F,PIR_SUPERFAMILY[630002140$PIRSF002002:leukocyte antigen-related receptor-type tyrosine-protein phosphatases]
protein tyrosine phosphatase, receptor type, F,SMART[760000051$SM00060:FN3, 760000168$SM00194:PTPc, 760000356$SM00408:IGc2]
protein tyrosine phosphatase, receptor type, F,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, receptor type, F,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850056944$chain:Receptor-type tyrosine-protein phosphatase F, 850102883$disulfide bond, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850103871$domain:Fibronectin type-III 4, 850103882$domain:Fibronectin type-III 5, 850103893$domain:Fibronectin type-III 6, 850103905$domain:Fibronectin type-III 7, 850103917$domain:Fibronectin type-III 8, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105594$domain:Tyrosine-protein phosphatase 1, 850105595$domain:Tyrosine-protein phosphatase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450010372$IPR011510:Sterile alpha motif homology 2]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,PIR_SUPERFAMILY[630018477$PIRSF022556:LAR-interacting protein]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,SMART[760000399$SM00454:SAM]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,UP_SEQ_FEATURE[850028886$chain:Liprin-alpha-2, 850102507$compositionally biased region:Glu-rich, 850102568$compositionally biased region:Poly-Asp, 850105250$domain:SAM 1, 850105251$domain:SAM 2, 850105252$domain:SAM 3, 850106258$modified residue]
purinergic receptor P2Y, G-protein coupled, 2,BIOCARTA[30000166$h_ionPathway:Ion Channel and Phorbal Esters Signaling Pathway]
purinergic receptor P2Y, G-protein coupled, 2,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000306$IPR000356:P2U purinoceptor, 450002032$IPR002286:P2 purinoceptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
purinergic receptor P2Y, G-protein coupled, 2,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
purinergic receptor P2Y, G-protein coupled, 2,PIR_SUPERFAMILY[630005369$PIRSF005445:P2Y purinoceptors 1/2/3/4/6, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
purinergic receptor P2Y, G-protein coupled, 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
purinergic receptor P2Y, G-protein coupled, 2,UP_SEQ_FEATURE[850036628$chain:P2Y purinoceptor 2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ras responsive element binding protein 1,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
ras responsive element binding protein 1,SMART[760000323$SM00355:ZnF_C2H2]
ras responsive element binding protein 1,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
ras responsive element binding protein 1,UP_SEQ_FEATURE[850056861$chain:Ras-responsive element-binding protein 1, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
remodeling and spacing factor 1,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
remodeling and spacing factor 1,SMART[760000221$SM00249:PHD]
remodeling and spacing factor 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
remodeling and spacing factor 1,UP_SEQ_FEATURE[850057163$chain:Remodeling and spacing factor 1, 850102404$compositionally biased region:Arg-rich, 850102507$compositionally biased region:Glu-rich, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850103505$domain:DDT, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118877$zinc finger region:PHD-type]
rhomboid domain containing 2,INTERPRO[450002317$IPR002610:Peptidase S54, rhomboid]
rhomboid domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
rhomboid domain containing 2,UP_SEQ_FEATURE[850057628$chain:Rhomboid domain-containing protein 2, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
ribonuclease, RNase K,SP_PIR_KEYWORDS[790000356$complete proteome, 790000498$Endonuclease, 790000743$hydrolase, 790000919$membrane, 790001049$nuclease, 790001555$transmembrane]
ribonuclease, RNase K,UP_SEQ_FEATURE[850057719$chain:Ribonuclease kappa, 850118623$transmembrane region]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,INTERPRO[450001225$IPR001380:Ribosomal protein L13e, 450016541$IPR018256:Ribosomal protein L13e, conserved site]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,PIR_SUPERFAMILY[630002353$PIRSF002221:ribosomal protein L13]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000411$cytosol, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,UP_SEQ_FEATURE[850002608$chain:60S ribosomal protein L13, 850106258$modified residue, 850117295$sequence variant]
ribosomal protein L26-like 1,INTERPRO[450005210$IPR005756:Ribosomal protein L26, eukaryotic/archaeal, 450005271$IPR005824:KOW, 450005272$IPR005825:Ribosomal protein L24/L26, conserved site, 450013175$IPR014723:Ribosomal protein L24, SH3-like]
ribosomal protein L26-like 1,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L26-like 1,PIR_SUPERFAMILY[630002335$PIRSF002204:ribosomal protein L26]
ribosomal protein L26-like 1,SMART[760000645$SM00739:KOW]
ribosomal protein L26-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001325$ribonucleoprotein, 790001329$ribosomal protein]
ribosomal protein L26-like 1,UP_SEQ_FEATURE[850002697$chain:60S ribosomal protein L26-like 1]
ribosomal protein L27a,INTERPRO[450001051$IPR001196:Ribosomal protein L15]
ribosomal protein L27a,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L27a,PIR_SUPERFAMILY[630002306$PIRSF002174:ribosomal protein, 15L type, 630030997$PIRSF500843:60S ribosomal protein L27a]
ribosomal protein L27a,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein, 790001325$ribonucleoprotein, 790001329$ribosomal protein]
ribosomal protein L27a,UP_SEQ_FEATURE[850002705$chain:60S ribosomal protein L27a, 850106258$modified residue]
ribosomal protein S6 kinase, 52kDa, polypeptide 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001492$IPR001683:Phox-like, 450006694$IPR007330:MIT, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
ribosomal protein S6 kinase, 52kDa, polypeptide 1,SMART[760000282$SM00312:PX, 760000651$SM00745:MIT]
ribosomal protein S6 kinase, 52kDa, polypeptide 1,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001329$ribosomal protein, 790001388$serine/threonine-protein kinase, 790001547$transferase]
ribosomal protein S6 kinase, 52kDa, polypeptide 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850057908$chain:Ribosomal protein S6 kinase delta-1, 850104790$domain:MIT, 850105087$domain:Protein kinase 1, 850105088$domain:Protein kinase 2, 850105129$domain:PX, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
ring finger protein 5; ring finger protein 5 pseudogene 1,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 5; ring finger protein 5 pseudogene 1,SMART[760000158$SM00184:RING]
ring finger protein 5; ring finger protein 5 pseudogene 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000859$ligase, 790000919$membrane, 790000937$metal-binding, 790001555$transmembrane, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 5; ring finger protein 5 pseudogene 1,UP_SEQ_FEATURE[850016727$chain:E3 ubiquitin-protein ligase RNF5, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118623$transmembrane region, 850118911$zinc finger region:RING-type]
secretoglobin, family 2A, member 2,INTERPRO[450003185$IPR003627:Mammaglobin/Prostatein, 450005477$IPR006038:Uteroglobin-like superfamily, 450005478$IPR006039:Uteroglobin-like family, 450014487$IPR016126:Secretoglobin]
secretoglobin, family 2A, member 2,PIR_SUPERFAMILY[630002653$PIRSF002537:uteroglobin]
secretoglobin, family 2A, member 2,SMART[760000084$SM00096:UTG]
secretoglobin, family 2A, member 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790001405$signal]
secretoglobin, family 2A, member 2,UP_SEQ_FEATURE[850030348$chain:Mammaglobin-A, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),INTERPRO[450001441$IPR001627:Semaphorin/CD100 antigen, 450001920$IPR002165:Plexin, 450003160$IPR003599:Immunoglobulin subtype, 450003205$IPR003659:Plexin/semaphorin/integrin, 450006486$IPR007110:Immunoglobulin-like, 450014355$IPR015943:WD40/YVTN repeat-like]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),OMIM_DISEASE[520000602$Blood group, John-Milton-Hagen]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),PIR_SUPERFAMILY[630005453$PIRSF005526:semaphorin]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),SMART[760000357$SM00409:IG, 760000369$SM00423:PSI, 760000545$SM00630:Sema]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000768$Immunoglobulin domain, 790000881$lipoprotein, 790000919$membrane, 790001016$neurogenesis, 790001212$polymorphism, 790001405$signal]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),UP_SEQ_FEATURE[850059312$chain:Semaphorin-7A, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105337$domain:Sema, 850105770$glycosylation site:N-linked (GlcNAc...), 850105855$lipid moiety-binding region:GPI-anchor amidated alanine, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide]
sestrin 2,INTERPRO[450006137$IPR006730:PA26 p53-induced protein (sestrin)]
sestrin 2,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
sestrin 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
sestrin 2,UP_SEQ_FEATURE[850060442$chain:Sestrin-2, 850117295$sequence variant]
sideroflexin 2,INTERPRO[450004176$IPR004686:Tricarboxylate/iron carrier]
sideroflexin 2,PIR_SUPERFAMILY[630008487$PIRSF009336:probable membrane protein]
sideroflexin 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000798$ion transport, 790000802$iron, 790000805$iron transport, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane, 790001558$transport]
sideroflexin 2,UP_SEQ_FEATURE[850060715$chain:Sideroflexin-2, 850117294$sequence conflict, 850118623$transmembrane region]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),INTERPRO[450017580$IPR019342:NADH:ubiquinone oxidoreductase, subunit 5]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),PIR_SUPERFAMILY[630019062$PIRSF023963:NADH dehydrogenase [ubiquinone] (complex I), iron-sulfur subunit 5]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),SP_PIR_KEYWORDS[790000356$complete proteome, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001309$respiratory chain, 790001558$transport, 790001589$ubiquinone]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),UP_SEQ_FEATURE[850033549$chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 5]
similar to Putative uncharacterized protein C6orf99; chromosome 6 open reading frame 99,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
similar to Putative uncharacterized protein C6orf99; chromosome 6 open reading frame 99,UP_SEQ_FEATURE[850055318$chain:Putative uncharacterized protein C6orf99, 850118574$splice variant]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),INTERPRO[450006867$IPR007513:Four F5 protein]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),UP_SEQ_FEATURE[850060991$chain:Small EDRK-rich factor 1, 850118574$splice variant]
small proline-rich protein 2D,INTERPRO[450002847$IPR003267:Small proline-rich]
small proline-rich protein 2D,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000822$keratinization, 790001212$polymorphism, 790001304$repeat]
small proline-rich protein 2D,UP_SEQ_FEATURE[850061037$chain:Small proline-rich protein 2D, 850110281$region of interest:3 X 9 AA tandem repeats of P-K-C-P-[EQ]- P-C-P-[PS], 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850117294$sequence conflict, 850117295$sequence variant]
solute carrier family 22 (organic anion transporter), member 6,INTERPRO[450004237$IPR004749:Organic cation transport protein, 450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 22 (organic anion transporter), member 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
solute carrier family 22 (organic anion transporter), member 6,UP_SEQ_FEATURE[850061405$chain:Solute carrier family 22 member 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118265$site:Important for interaction with cidofovir, 850118266$site:Important for interaction with cidofovir and PAH, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 22 (organic anion/urate transporter), member 12,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 22 (organic anion/urate transporter), member 12,OMIM_DISEASE[520002574$Hypouricemia, renal]
solute carrier family 22 (organic anion/urate transporter), member 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier family 22 (organic anion/urate transporter), member 12,UP_SEQ_FEATURE[850061388$chain:Solute carrier family 22 member 12, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,UP_SEQ_FEATURE[850031828$chain:Mitochondrial 2-oxodicarboxylate carrier, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 25, member 44,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25, member 44,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
solute carrier family 25, member 44,UP_SEQ_FEATURE[850061428$chain:Solute carrier family 25 member 44, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
spermatogenesis and centriole associated 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton]
spermatogenesis and centriole associated 1,UP_SEQ_FEATURE[850061779$chain:Speriolin, 850113697$region of interest:Necessary for targeting centrosomes, 850117294$sequence conflict]
spermatogenesis associated 5,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
spermatogenesis associated 5,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
spermatogenesis associated 5,PIR_SUPERFAMILY[630001318$PIRSF001172:AAA ATPase, Nsf/Cdc48/Vcp types]
spermatogenesis associated 5,SMART[760000335$SM00382:AAA]
spermatogenesis associated 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001426$spermatogenesis]
spermatogenesis associated 5,UP_SEQ_FEATURE[850061890$chain:Spermatogenesis-associated protein 5, 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
sphingosine-1-phosphate receptor 1,BIOCARTA[30000088$h_edg1Pathway:Phospholipids as signalling intermediaries]
sphingosine-1-phosphate receptor 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000859$IPR000987:EDG-1 sphingosine 1-phosphate receptor, 450003577$IPR004061:Sphingosine 1-phosphate receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
sphingosine-1-phosphate receptor 1,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
sphingosine-1-phosphate receptor 1,PIR_SUPERFAMILY[630005359$PIRSF005435:LPAR1/S1PR1-like lysophospholipid receptor, 630031145$PIRSF501018:sphingosine 1-phosphate receptor 1-5, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
sphingosine-1-phosphate receptor 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
sphingosine-1-phosphate receptor 1,UP_SEQ_FEATURE[850061964$chain:Sphingosine 1-phosphate receptor 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
spondin 2, extracellular matrix protein,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450008568$IPR009465:Spondin, N-terminal]
spondin 2, extracellular matrix protein,OMIM_DISEASE[520004444$Sequence Variants in the RNF212 Gene Associate with Genomewide Recombination Rate]
spondin 2, extracellular matrix protein,SMART[760000182$SM00209:TSP1]
spondin 2, extracellular matrix protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000763$immune response, 790000937$metal-binding, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
spondin 2, extracellular matrix protein,UP_SEQ_FEATURE[850062093$chain:Spondin-2, 850102883$disulfide bond, 850105381$domain:Spondin, 850105554$domain:TSP type-1, 850105756$glycosylation site:C-linked (Man), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850105986$metal ion-binding site:Divalent metal cation, 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118272$site:Important for metal ion-dependent interaction with integrin, 850118575$strand, 850118624$turn]
stimulated by retinoic acid gene 6 homolog (mouse),OMIM_DISEASE[520003312$Microphthalmia, syndromic 9]
stimulated by retinoic acid gene 6 homolog (mouse),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000919$membrane, 790000958$microphthalmia, 790001212$polymorphism, 790001301$receptor, 790001555$transmembrane, 790001558$transport]
stimulated by retinoic acid gene 6 homolog (mouse),UP_SEQ_FEATURE[850062501$chain:Stimulated by retinoic acid gene 6 protein homolog, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
suppressor of cytokine signaling 2,INTERPRO[450000852$IPR000980:SH2 motif, 450001330$IPR001496:SOCS protein, C-terminal]
suppressor of cytokine signaling 2,KEGG_PATHWAY[470038866$hsa04630:Jak-STAT signaling pathway, 470038882$hsa04910:Insulin signaling pathway, 470038887$hsa04930:Type II diabetes mellitus]
suppressor of cytokine signaling 2,OMIM_DISEASE[520001993$Genome-wide association analysis identifies 20 loci that influence adult height, 520003072$Many sequence variants affecting diversity of adult human height]
suppressor of cytokine signaling 2,PIR_SUPERFAMILY[630006289$PIRSF006354:suppressor of cytokine signaling (SOCS) 1-3]
suppressor of cytokine signaling 2,SMART[760000224$SM00252:SH2, 760000225$SM00253:SOCS]
suppressor of cytokine signaling 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000635$growth regulation, 790001212$polymorphism, 790001397$SH2 domain, 790001408$Signal transduction inhibitor, 790001593$ubl conjugation pathway]
suppressor of cytokine signaling 2,UP_SEQ_FEATURE[850062984$chain:Suppressor of cytokine signaling 2, 850105346$domain:SH2, 850105375$domain:SOCS box, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
taste receptor, type 2, member 3,INTERPRO[450007304$IPR007960:Mammalian taste receptor]
taste receptor, type 2, member 3,KEGG_PATHWAY[470038880$hsa04742:Taste transduction]
taste receptor, type 2, member 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001377$sensory transduction, 790001487$Taste, 790001546$transducer, 790001555$transmembrane]
taste receptor, type 2, member 3,UP_SEQ_FEATURE[850063573$chain:Taste receptor type 2 member 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
tetraspanin 14,INTERPRO[450000259$IPR000301:Tetraspanin, subgroup, 450016772$IPR018499:Tetraspanin, 450016776$IPR018503:Tetraspanin, conserved site]
tetraspanin 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
tetraspanin 14,UP_SEQ_FEATURE[850063975$chain:Tetraspanin-14, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
tetratricopeptide repeat domain 17,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
tetratricopeptide repeat domain 17,SMART[760000020$SM00028:TPR]
tetratricopeptide repeat domain 17,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
tetratricopeptide repeat domain 17,UP_SEQ_FEATURE[850064000$chain:Tetratricopeptide repeat protein 17, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117295$sequence variant]
thioredoxin domain containing 12 (endoplasmic reticulum),INTERPRO[450001169$IPR001327:Pyridine nucleotide-disulphide oxidoreductase, NAD-binding region, 450003614$IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation, 450011036$IPR012335:Thioredoxin fold, 450011694$IPR013027:FAD-dependent pyridine nucleotide-disulphide oxidoreductase, 450016249$IPR017936:Thioredoxin-like, 450016250$IPR017937:Thioredoxin, conserved site]
thioredoxin domain containing 12 (endoplasmic reticulum),KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
thioredoxin domain containing 12 (endoplasmic reticulum),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000466$dna-binding, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000969$mitochondrion, 790001065$nucleus, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001302$Redox-active center, 790001405$signal, 790001550$transit peptide]
thioredoxin domain containing 12 (endoplasmic reticulum),UP_SEQ_FEATURE[850000341$binding site:FAD, 850000344$binding site:FAD; via amide nitrogen and carbonyl oxygen, 850000345$binding site:FAD; via carbonyl oxygen, 850005862$chain:Apoptosis-inducing factor 1, mitochondrial, 850064220$chain:Thioredoxin domain-containing protein 12, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106285$nucleotide phosphate-binding region:FAD, 850111661$region of interest:FAD-dependent oxidoreductase, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
transmembrane and tetratricopeptide repeat containing 1,COG_ONTOLOGY[90000073$General function prediction only]
transmembrane and tetratricopeptide repeat containing 1,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450012242$IPR013618:Region of unknown function DUF1736, 450017972$IPR019734:Tetratricopeptide repeat]
transmembrane and tetratricopeptide repeat containing 1,SMART[760000020$SM00028:TPR]
transmembrane and tetratricopeptide repeat containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001555$transmembrane]
transmembrane and tetratricopeptide repeat containing 1,UP_SEQ_FEATURE[850065924$chain:Transmembrane and TPR repeat-containing protein 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117119$repeat:TPR 1, 850117120$repeat:TPR 10, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
transmembrane and tetratricopeptide repeat containing 4,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450012242$IPR013618:Region of unknown function DUF1736, 450017972$IPR019734:Tetratricopeptide repeat]
transmembrane and tetratricopeptide repeat containing 4,SMART[760000020$SM00028:TPR]
transmembrane and tetratricopeptide repeat containing 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001555$transmembrane]
transmembrane and tetratricopeptide repeat containing 4,UP_SEQ_FEATURE[850065927$chain:Transmembrane and TPR repeat-containing protein 4, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
transmembrane protein 79,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
transmembrane protein 79,UP_SEQ_FEATURE[850066221$chain:Transmembrane protein 79, 850106258$modified residue, 850117295$sequence variant, 850118623$transmembrane region]
tryptophan 2,3-dioxygenase,INTERPRO[450004450$IPR004981:Tryptophan 2,3-dioxygenase]
tryptophan 2,3-dioxygenase,KEGG_PATHWAY[470038756$hsa00380:Tryptophan metabolism]
tryptophan 2,3-dioxygenase,PIR_SUPERFAMILY[630013551$PIRSF016768:PIRSF016768]
tryptophan 2,3-dioxygenase,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000437$dioxygenase, 790000652$heme, 790000802$iron, 790000937$metal-binding, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001576$tryptophan catabolism]
tryptophan 2,3-dioxygenase,UP_SEQ_FEATURE[850000390$binding site:Heme, 850000555$binding site:Substrate, 850067006$chain:Tryptophan 2,3-dioxygenase, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106258$modified residue, 850114716$region of interest:Substrate binding]
tubulin tyrosine ligase-like family, member 3; actin related protein 2/3 complex, subunit 4, 20kDa,INTERPRO[450003853$IPR004344:Tubulin-tyrosine ligase, 450007661$IPR008384:ARP23 complex 20 kDa subunit]
tubulin tyrosine ligase-like family, member 3; actin related protein 2/3 complex, subunit 4, 20kDa,KEGG_PATHWAY[470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038898$hsa05130:Pathogenic Escherichia coli infection]
tubulin tyrosine ligase-like family, member 3; actin related protein 2/3 complex, subunit 4, 20kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000859$ligase, 790000960$microtubule, 790001212$polymorphism]
tubulin tyrosine ligase-like family, member 3; actin related protein 2/3 complex, subunit 4, 20kDa,UP_SEQ_FEATURE[850003630$chain:Actin-related protein 2/3 complex subunit 4, 850067132$chain:Tubulin monoglycylase TTLL3, 850105582$domain:TTL, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
tumor protein p53 regulated apoptosis inducing protein 1,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
tumor protein p53 regulated apoptosis inducing protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism]
tumor protein p53 regulated apoptosis inducing protein 1,UP_SEQ_FEATURE[850036662$chain:p53-regulated apoptosis-inducing protein 1, 850117295$sequence variant, 850118574$splice variant]
ubiquinol-cytochrome c reductase complex chaperone,INTERPRO[450006502$IPR007129:Ubiquinol-cytochrome C chaperone]
ubiquinol-cytochrome c reductase complex chaperone,OMIM_DISEASE[520001131$Common variants in the GDF5-UQCC region are associated with variation in human height, 520002597$Identification of ten loci associated with height highlights new biological pathways in human growth, 520003072$Many sequence variants affecting diversity of adult human height, 520004687$Stature quantitative trait locus 14]
ubiquinol-cytochrome c reductase complex chaperone,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790001212$polymorphism]
ubiquinol-cytochrome c reductase complex chaperone,UP_SEQ_FEATURE[850067925$chain:Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ubiquitin protein ligase E3 component n-recognin 1,INTERPRO[450002750$IPR003126:Zinc finger, N-recognin, 450003310$IPR003769:Adaptor protein ClpS, core, 450012587$IPR013993:Zinc finger, N-recognin,  metazoa, 450013171$IPR014719:Ribosomal protein L7/L12, C-terminal/adaptor protein ClpS-like, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
ubiquitin protein ligase E3 component n-recognin 1,OMIM_DISEASE[520002692$Johanson-Blizzard syndrome]
ubiquitin protein ligase E3 component n-recognin 1,SMART[760000347$SM00396:ZnF_UBR1]
ubiquitin protein ligase E3 component n-recognin 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000859$ligase, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ubiquitin protein ligase E3 component n-recognin 1,UP_SEQ_FEATURE[850016773$chain:E3 ubiquitin-protein ligase UBR1, 850102580$compositionally biased region:Poly-Pro, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118919$zinc finger region:RING-type; atypical, 850118948$zinc finger region:UBR-type]
up-regulated during skeletal muscle growth 5 homolog (mouse),INTERPRO[450008245$IPR009125:DAPIT]
up-regulated during skeletal muscle growth 5 homolog (mouse),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane]
up-regulated during skeletal muscle growth 5 homolog (mouse),UP_SEQ_FEATURE[850083125$chain:Up-regulated during skeletal muscle growth protein 5, 850106258$modified residue, 850118623$transmembrane region]
vascular cell adhesion molecule 1,BBID[10000045$17.Activators-CAM, 10000046$18.Cytokine_astocytes, 10000078$58.(CD40L)_immnosurveillance, 10000117$96.Immune_injury_MS-lesions_genetic_environ]
vascular cell adhesion molecule 1,BIOCARTA[30000169$h_LairPathway:Cells and Molecules involved in local acute inflammatory response, 30000175$h_lympathway:Adhesion and Diapedesis of Lymphocytes]
vascular cell adhesion molecule 1,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450003510$IPR003987:Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal, 450003512$IPR003989:Vascular cell adhesion molecule-1, 450006486$IPR007110:Immunoglobulin-like, 450007701$IPR008424:Immunoglobulin C2-set, 450011742$IPR013098:Immunoglobulin I-set, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
vascular cell adhesion molecule 1,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038873$hsa04670:Leukocyte transendothelial migration]
vascular cell adhesion molecule 1,PIR_SUPERFAMILY[630030191$PIRSF038689:vascular cell adhesion protein 1]
vascular cell adhesion molecule 1,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
vascular cell adhesion molecule 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
vascular cell adhesion molecule 1,UP_SEQ_FEATURE[850100065$chain:Vascular cell adhesion protein 1, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104403$domain:Ig-like C2-type 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
vesicle-associated membrane protein 4,INTERPRO[450001233$IPR001388:Synaptobrevin, 450014766$IPR016444:Synaptobrevin, metazoa/fungi]
vesicle-associated membrane protein 4,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
vesicle-associated membrane protein 4,PIR_SUPERFAMILY[630005334$PIRSF005409:Synaptobrevin_euk]
vesicle-associated membrane protein 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
vesicle-associated membrane protein 4,UP_SEQ_FEATURE[850100234$chain:Vesicle-associated membrane protein 4, 850105618$domain:v-SNARE coiled-coil homology, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
vinculin,BIOCARTA[30000058$h_cell2cellPathway:Cell to Cell Adhesion Signaling, 30000164$h_integrinPathway:Integrin Signaling Pathway, 30000261$h_rhoPathway:Rho cell motility signaling pathway]
vinculin,INTERPRO[450000541$IPR000633:Vinculin, conserved site, 450005513$IPR006077:Vinculin/alpha-catenin, 450016305$IPR017997:Vinculin]
vinculin,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038856$hsa04520:Adherens junction, 470038873$hsa04670:Leukocyte transendothelial migration, 470038881$hsa04810:Regulation of actin cytoskeleton]
vinculin,OMIM_DISEASE[520000785$Cardiomyopathy, dilated, 1W]
vinculin,PIR_SUPERFAMILY[630002419$PIRSF002293:meta-vinculin]
vinculin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000245$Cardiomyopathy, 790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000446$disease mutation, 790000473$duplication, 790000867$lipid binding, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
vinculin,UP_SEQ_FEATURE[850100321$chain:Vinculin, 850102586$compositionally biased region:Pro-rich, 850105852$helix, 850106258$modified residue, 850110194$region of interest:3 X 112 AA tandem repeats, 850114848$region of interest:Talin-interaction, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
zinc finger and BTB domain containing 8A,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006475$IPR007087:Zinc finger, C2H2-type, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger and BTB domain containing 8A,SMART[760000197$SM00225:BTB, 760000323$SM00355:ZnF_C2H2]
zinc finger and BTB domain containing 8A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger and BTB domain containing 8A,UP_SEQ_FEATURE[850101258$chain:Zinc finger and BTB domain-containing protein 8A, 850102572$compositionally biased region:Poly-Glu, 850103177$domain:BTB, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2]
zinc finger protein 205,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 205,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 205,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 205,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 205,UP_SEQ_FEATURE[850101491$chain:Zinc finger protein 205, 850104552$domain:KRAB, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8]
zinc finger protein 34,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 34,INTERPRO[450001661$IPR001878:Zinc finger, CCHC-type, 450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 34,PIR_SUPERFAMILY[630005483$PIRSF005559:zinc finger protein ZFP-36]
zinc finger protein 34,SMART[760000311$SM00343:ZnF_C2HC, 760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 34,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 34,UP_SEQ_FEATURE[850101588$chain:Zinc finger protein 34, 850104552$domain:KRAB, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 365,INTERPRO[450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 365,OMIM_DISEASE[520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease, 520003564$Nephrolithiasis, uric acid, susceptibility to, 520004984$uric acid nephrolithiasis]
zinc finger protein 365,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 365,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
zinc finger protein 365,UP_SEQ_FEATURE[850048572$chain:Protein ZNF365, 850063511$chain:Talanin, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
zinc finger protein 408,COG_ONTOLOGY[90000118$Transcription / Cell division and chromosome partitioning]
zinc finger protein 408,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 408,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 408,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 408,UP_SEQ_FEATURE[850101625$chain:Zinc finger protein 408, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 705A,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 705A,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 705A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 705A,UP_SEQ_FEATURE[850101874$chain:Zinc finger protein 705A, 850104552$domain:KRAB, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
zinc finger, MYND domain containing 11,INTERPRO[450000267$IPR000313:PWWP, 450001324$IPR001487:Bromodomain, 450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450002557$IPR002893:Zinc finger, MYND-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
zinc finger, MYND domain containing 11,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000264$SM00293:PWWP, 760000267$SM00297:BROMO]
zinc finger, MYND domain containing 11,SP_PIR_KEYWORDS[790000206$bromodomain, 790000258$cell cycle, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger, MYND domain containing 11,UP_SEQ_FEATURE[850101422$chain:Zinc finger MYND domain-containing protein 11, 850103166$domain:Bromo, 850105126$domain:PWWP, 850106258$modified residue, 850114256$region of interest:Required for binding to E1A, 850117610$short sequence motif:Nuclear localization signal, 850118853$zinc finger region:MYND-type, 850118877$zinc finger region:PHD-type]
